{
"instance": {
"isrg-20200930.htm": {
"axisCustom": 2,
"axisStandard": 18,
"contextCount": 238,
"dts": {
"calculationLink": {
"local": [
"isrg-20200930_cal.xml"
]
},
"definitionLink": {
"local": [
"isrg-20200930_def.xml"
],
"remote": [
"http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
"http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
]
},
"inline": {
"local": [
"isrg-20200930.htm"
]
},
"labelLink": {
"local": [
"isrg-20200930_lab.xml"
],
"remote": [
"https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
"http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml"
]
},
"presentationLink": {
"local": [
"isrg-20200930_pre.xml"
]
},
"referenceLink": {
"remote": [
"http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml",
"https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
]
},
"schema": {
"local": [
"isrg-20200930.xsd"
],
"remote": [
"http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
"http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
"http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
"http://www.xbrl.org/2003/xl-2003-12-31.xsd",
"http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
"http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
"http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
"http://www.xbrl.org/2005/xbrldt-2005.xsd",
"http://www.xbrl.org/2006/ref-2006-02-27.xsd",
"http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
"http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
"http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
"http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
"https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
"http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
"https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
"http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
"http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd"
]
}
},
"elementCount": 506,
"entityCount": 1,
"hidden": {
"http://xbrl.sec.gov/dei/2019-01-31": 5,
"total": 5
},
"keyCustom": 25,
"keyStandard": 357,
"memberCustom": 17,
"memberStandard": 39,
"nsprefix": "isrg",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"report": {
"R1": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "document",
"isDefault": "true",
"longName": "0001001 - Document - Cover Page",
"role": "http://www.intuitivesurgical.com/role/CoverPage",
"shortName": "Cover Page",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R10": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2121105 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS",
"role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS",
"shortName": "REVENUE AND CONTRACT ACQUISITION COSTS",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R11": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:LessorSalesTypeLeasesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2127106 - Disclosure - LEASES",
"role": "http://www.intuitivesurgical.com/role/LEASES",
"shortName": "LEASES",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:LessorSalesTypeLeasesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R12": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2131107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
"role": "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS",
"shortName": "GOODWILL AND INTANGIBLE ASSETS",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R13": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2137108 - Disclosure - CONTINGENCIES",
"role": "http://www.intuitivesurgical.com/role/CONTINGENCIES",
"shortName": "CONTINGENCIES",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R14": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2138109 - Disclosure - STOCKHOLDERS' EQUITY",
"role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY",
"shortName": "STOCKHOLDERS' EQUITY",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R15": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2144110 - Disclosure - SHARE-BASED COMPENSATION",
"role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION",
"shortName": "SHARE-BASED COMPENSATION",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R16": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:IncomeTaxDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2151111 - Disclosure - INCOME TAXES",
"role": "http://www.intuitivesurgical.com/role/INCOMETAXES",
"shortName": "INCOME TAXES",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:IncomeTaxDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R17": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:EarningsPerShareTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2153112 - Disclosure - NET INCOME PER SHARE",
"role": "http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE",
"shortName": "NET INCOME PER SHARE",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:EarningsPerShareTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R18": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
"role": "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
"shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
"subGroupType": "policies",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R19": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2303301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
"role": "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
"shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R2": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:AvailableForSaleSecuritiesTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
"role": "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"lang": "en-US",
"name": "us-gaap:AccountsReceivableNetCurrent",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R20": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:AvailableForSaleSecuritiesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2308302 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
"role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables",
"shortName": "FINANCIAL INSTRUMENTS (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:AvailableForSaleSecuritiesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R21": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2315303 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION (Tables)",
"role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables",
"shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R22": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2322304 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS (Tables)",
"role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables",
"shortName": "REVENUE AND CONTRACT ACQUISITION COSTS (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R23": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2328305 - Disclosure - LEASES (Tables)",
"role": "http://www.intuitivesurgical.com/role/LEASESTables",
"shortName": "LEASES (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R24": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfGoodwillTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2332306 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
"role": "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables",
"shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfGoodwillTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R25": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2339307 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
"role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables",
"shortName": "STOCKHOLDERS' EQUITY (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R26": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2345308 - Disclosure - SHARE-BASED COMPENSATION (Tables)",
"role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables",
"shortName": "SHARE-BASED COMPENSATION (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R27": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2354309 - Disclosure - NET INCOME PER SHARE (Tables)",
"role": "http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables",
"shortName": "NET INCOME PER SHARE (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R28": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "isrg:ServiceFeeCredit",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2405401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)",
"role": "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails",
"shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "isrg:ServiceFeeCredit",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R29": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"ix:continuation",
"div",
"ix:continuation",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Amortized Cost Basis by Year of Origination and Credit Quality Indicator (Details)",
"role": "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails",
"shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Amortized Cost Basis by Year of Origination and Credit Quality Indicator (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"ix:continuation",
"div",
"ix:continuation",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R3": {
"firstAnchor": {
"ancestors": [
"us-gaap:PreferredStockSharesAuthorized",
"span",
"div",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "INF",
"first": true,
"lang": "en-US",
"name": "us-gaap:PreferredStockSharesAuthorized",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
"role": "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
"shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
"subGroupType": "parenthetical",
"uniqueAnchor": {
"ancestors": [
"us-gaap:PreferredStockSharesAuthorized",
"span",
"div",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "INF",
"first": true,
"lang": "en-US",
"name": "us-gaap:PreferredStockSharesAuthorized",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
}
},
"R30": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:AvailableForSaleSecuritiesTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2409403 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details)",
"role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
"shortName": "FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:AvailableForSaleSecuritiesTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"lang": "en-US",
"name": "isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R31": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2410404 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments (Details)",
"role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails",
"shortName": "FINANCIAL INSTRUMENTS - Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R32": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
"us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "ib7f9e6f7962e4bea9ff0a787a490dcfa_I20191231",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:EquitySecuritiesFvNi",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2411405 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Equity Investment Activity (Details)",
"role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails",
"shortName": "FINANCIAL INSTRUMENTS - Summary of Equity Investment Activity (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "ia6e61c8e06484f25b752d51db98c111d_I20191231",
"decimals": "-5",
"lang": "en-US",
"name": "us-gaap:EquitySecuritiesFvNi",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R33": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2412406 - Disclosure - FINANCIAL INSTRUMENTS - Derivative Instruments Used to Hedge against Balance Sheet Foreign Currency Exposures (Details)",
"role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
"shortName": "FINANCIAL INSTRUMENTS - Derivative Instruments Used to Hedge against Balance Sheet Foreign Currency Exposures (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R34": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i91e83e95d23d4794850ebd91d233a76e_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:DerivativeNotionalAmount",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2413407 - Disclosure - FINANCIAL INSTRUMENTS - Gross Notional Amounts for Outstanding Derivatives (Details)",
"role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails",
"shortName": "FINANCIAL INSTRUMENTS - Gross Notional Amounts for Outstanding Derivatives (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i91e83e95d23d4794850ebd91d233a76e_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:DerivativeNotionalAmount",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R35": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:InventoryRawMaterialsNetOfReserves",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2416408 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Inventory (Details)",
"role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails",
"shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Inventory (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:InventoryRawMaterialsNetOfReserves",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R36": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
"us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:PrepaidTaxes",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2417409 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Prepaids and Other Current Assets (Details)",
"role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails",
"shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Prepaids and Other Current Assets (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
"us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:PrepaidTaxes",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R37": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"us-gaap:OtherCurrentLiabilitiesTableTextBlock",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:TaxesPayableCurrent",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2418410 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Accrued Liabilities - Short-term (Details)",
"role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails",
"shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Accrued Liabilities - Short-term (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"us-gaap:OtherCurrentLiabilitiesTableTextBlock",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:TaxesPayableCurrent",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R38": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:AccruedIncomeTaxesNoncurrent",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2419411 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Long-term Liabilities (Details)",
"role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails",
"shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Long-term Liabilities (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:AccruedIncomeTaxesNoncurrent",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R39": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:PropertyPlantAndEquipmentTransfersAndChanges",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2420412 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Supplemental Cash Flow Information (Details)",
"role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails",
"shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Supplemental Cash Flow Information (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:PropertyPlantAndEquipmentTransfersAndChanges",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R4": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:DisaggregationOfRevenueTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1003004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
"role": "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
"shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-5",
"lang": "en-US",
"name": "us-gaap:CostOfGoodsAndServicesSold",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R40": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:DisaggregationOfRevenueTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2423413 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Revenue Disaggregated by Types and Geography (Details)",
"role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails",
"shortName": "REVENUE AND CONTRACT ACQUISITION COSTS - Revenue Disaggregated by Types and Geography (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:DisaggregationOfRevenueTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "ic7fbd19ededa40d596bcc2c49147d224_D20200701-20200930",
"decimals": "-5",
"lang": "en-US",
"name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R41": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:RevenueRemainingPerformanceObligation",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2424414 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details)",
"role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails",
"shortName": "REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-5",
"lang": "en-US",
"name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R42": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:ContractWithCustomerAssetNet",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2425415 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Summary of Contract Assets and Liabilities (Details)",
"role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails",
"shortName": "REVENUE AND CONTRACT ACQUISITION COSTS - Summary of Contract Assets and Liabilities (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:ContractWithCustomerAssetNet",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R43": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock",
"us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:SalesTypeLeaseLeaseIncome",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2426416 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Sales-type and Operating Lease Revenue (Details)",
"role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails",
"shortName": "REVENUE AND CONTRACT ACQUISITION COSTS - Sales-type and Operating Lease Revenue (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock",
"us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:SalesTypeLeaseLeaseIncome",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R44": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"ix:continuation",
"div",
"isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "isrg:SalesTypeLeaseGrossInvestmentInLease",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2429417 - Disclosure - LEASES - Lease Receivables (Details)",
"role": "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails",
"shortName": "LEASES - Lease Receivables (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"ix:continuation",
"div",
"isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "isrg:SalesTypeLeaseGrossInvestmentInLease",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R45": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2430418 - Disclosure - LEASES - Schedule of Contractual Maturities of Gross Lease Receivables (Details)",
"role": "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails",
"shortName": "LEASES - Schedule of Contractual Maturities of Gross Lease Receivables (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R46": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "isrg:BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2433419 - Disclosure - Intangible Assets, Goodwill and Other (Details)",
"role": "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails",
"shortName": "Intangible Assets, Goodwill and Other (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "ia72f1b646b6e4956aaa847b9d7df00d4_D20190105-20190105",
"decimals": "-5",
"lang": "en-US",
"name": "us-gaap:BusinessCombinationConsiderationTransferred1",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R47": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfGoodwillTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "ib7f9e6f7962e4bea9ff0a787a490dcfa_I20191231",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:Goodwill",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2434420 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Summary of Changes in Goodwill (Details)",
"role": "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails",
"shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule of Summary of Changes in Goodwill (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfGoodwillTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": "-5",
"lang": "en-US",
"name": "us-gaap:GoodwillAcquiredDuringPeriod",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R48": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:FiniteLivedIntangibleAssetsGross",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2435421 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details)",
"role": "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails",
"shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:FiniteLivedIntangibleAssetsGross",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R49": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2436422 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule Of Estimated Future Amortization Expense Of Intangible Assets (Details)",
"role": "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails",
"shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule Of Estimated Future Amortization Expense Of Intangible Assets (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R5": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:ProfitLoss",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1004005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
"role": "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
"shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": "-5",
"lang": "en-US",
"name": "us-gaap:Depreciation",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R50": {
"firstAnchor": {
"ancestors": [
"us-gaap:CommonStockSharesIssued",
"span",
"div",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "ib7f9e6f7962e4bea9ff0a787a490dcfa_I20191231",
"decimals": "-3",
"first": true,
"lang": "en-US",
"name": "us-gaap:CommonStockSharesOutstanding",
"reportCount": 1,
"unitRef": "shares",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2440423 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Stockholders Equity (Details)",
"role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails",
"shortName": "STOCKHOLDERS' EQUITY - Schedule of Stockholders Equity (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i708e1e2de17e4fc386c7b7090ebbd8eb_I20200630",
"decimals": "-5",
"lang": "en-US",
"name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R51": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"ix:continuation",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i475af94a04604b0482821d3276feea54_D20190701-20190930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodValue",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2441424 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Share Repurchase Activities (Details)",
"role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
"shortName": "STOCKHOLDERS' EQUITY - Schedule of Share Repurchase Activities (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i9b01e4ae4cc0438d9cb0699f255f858b_D20200701-20200930",
"decimals": "-5",
"lang": "en-US",
"name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
}
},
"R52": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:PaymentsForRepurchaseOfCommonStock",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2442425 - Disclosure - STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)",
"role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails",
"shortName": "STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i629c689c9c414422879f411f2012e171_I20200930",
"decimals": "INF",
"lang": "en-US",
"name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R53": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i708e1e2de17e4fc386c7b7090ebbd8eb_I20200630",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2443426 - Disclosure - STOCKHOLDERS' EQUITY - Components of Accumulated Other Comprehensive Income, Net of Tax (Details)",
"role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails",
"shortName": "STOCKHOLDERS' EQUITY - Components of Accumulated Other Comprehensive Income, Net of Tax (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i708e1e2de17e4fc386c7b7090ebbd8eb_I20200630",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R54": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2446427 - Disclosure - SHARE-BASED COMPENSATION - Additional Information (Details)",
"role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
"shortName": "SHARE-BASED COMPENSATION - Additional Information (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i99c7425094924bd78250774a51f38d78_I20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
}
},
"R55": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "ib7f9e6f7962e4bea9ff0a787a490dcfa_I20191231",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2447428 - Disclosure - SHARE-BASED COMPENSATION - Summary of Stock Option Activity Under All Stock Plans (Details)",
"role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails",
"shortName": "SHARE-BASED COMPENSATION - Summary of Stock Option Activity Under All Stock Plans (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "ib7f9e6f7962e4bea9ff0a787a490dcfa_I20191231",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
}
},
"R56": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i90fb12615f4a4bdaa00cf784c7d4bd19_I20191231",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2448429 - Disclosure - SHARE-BASED COMPENSATION - Summary of RSU Activity (Details)",
"role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails",
"shortName": "SHARE-BASED COMPENSATION - Summary of RSU Activity (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i90fb12615f4a4bdaa00cf784c7d4bd19_I20191231",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
}
},
"R57": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:AllocatedShareBasedCompensationExpense",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2449430 - Disclosure - SHARE-BASED COMPENSATION - Stock-Based Compensation Expense (Details)",
"role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails",
"shortName": "SHARE-BASED COMPENSATION - Stock-Based Compensation Expense (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:AllocatedShareBasedCompensationExpense",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R58": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i5e00341cc7a543568ad8762762d77287_D20200701-20200930",
"decimals": "3",
"first": true,
"lang": "en-US",
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
"reportCount": 1,
"unique": true,
"unitRef": "number",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2450431 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Estimated Fair Value of Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions (Details)",
"role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails",
"shortName": "SHARE-BASED COMPENSATION - Schedule of Estimated Fair Value of Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i5e00341cc7a543568ad8762762d77287_D20200701-20200930",
"decimals": "3",
"first": true,
"lang": "en-US",
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
"reportCount": 1,
"unique": true,
"unitRef": "number",
"xsiNil": "false"
}
},
"R59": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:IncomeTaxExpenseBenefit",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2452432 - Disclosure - INCOME TAXES - Additional Information (Details)",
"role": "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails",
"shortName": "INCOME TAXES - Additional Information (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "3",
"lang": "en-US",
"name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
"reportCount": 1,
"unique": true,
"unitRef": "number",
"xsiNil": "false"
}
},
"R6": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:NatureOfOperations",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2101101 - Disclosure - DESCRIPTION OF THE BUSINESS",
"role": "http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS",
"shortName": "DESCRIPTION OF THE BUSINESS",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:NatureOfOperations",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R60": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:NetIncomeLoss",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2455433 - Disclosure - NET INCOME PER SHARE - Computation of Basic and Diluted Net Income Per Share (Details)",
"role": "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails",
"shortName": "NET INCOME PER SHARE - Computation of Basic and Diluted Net Income Per Share (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-5",
"lang": "en-US",
"name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
}
},
"R61": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2456434 - Disclosure - NET INCOME PER SHARE - Additional Information (Details)",
"role": "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails",
"shortName": "NET INCOME PER SHARE - Additional Information (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i1e5ed87166574d53b096a8e9066506e5_D20200701-20200930",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
}
},
"R7": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SignificantAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
"role": "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
"shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SignificantAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R8": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2107103 - Disclosure - FINANCIAL INSTRUMENTS",
"role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS",
"shortName": "FINANCIAL INSTRUMENTS",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R9": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2114104 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION",
"role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION",
"shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "isrg-20200930.htm",
"contextRef": "i12e147cb02084ad39c3687a781daa012_D20200101-20200930",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
}
},
"segmentCount": 56,
"tag": {
"dei_AmendmentFlag": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
"label": "Amendment Flag",
"terseLabel": "Amendment Flag"
}
}
},
"localname": "AmendmentFlag",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_CityAreaCode": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Area code of city",
"label": "City Area Code",
"terseLabel": "City Area Code"
}
}
},
"localname": "CityAreaCode",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_CoverAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Cover page.",
"label": "Cover [Abstract]",
"terseLabel": "Cover page."
}
}
},
"localname": "CoverAbstract",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"xbrltype": "stringItemType"
},
"dei_CurrentFiscalYearEndDate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "End date of current fiscal year in the format --MM-DD.",
"label": "Current Fiscal Year End Date",
"terseLabel": "Current Fiscal Year End Date"
}
}
},
"localname": "CurrentFiscalYearEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "gMonthDayItemType"
},
"dei_DocumentFiscalPeriodFocus": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
"label": "Document Fiscal Period Focus",
"terseLabel": "Document Fiscal Period Focus"
}
}
},
"localname": "DocumentFiscalPeriodFocus",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "fiscalPeriodItemType"
},
"dei_DocumentFiscalYearFocus": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
"label": "Document Fiscal Year Focus",
"terseLabel": "Document Fiscal Year Focus"
}
}
},
"localname": "DocumentFiscalYearFocus",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "gYearItemType"
},
"dei_DocumentPeriodEndDate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
"label": "Document Period End Date",
"terseLabel": "Document Period End Date"
}
}
},
"localname": "DocumentPeriodEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "dateItemType"
},
"dei_DocumentQuarterlyReport": {
"auth_ref": [
"r403"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true only for a form used as an quarterly report.",
"label": "Document Quarterly Report",
"terseLabel": "Document Quarterly Report"
}
}
},
"localname": "DocumentQuarterlyReport",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentTransitionReport": {
"auth_ref": [
"r404"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true only for a form used as a transition report.",
"label": "Document Transition Report",
"terseLabel": "Document Transition Report"
}
}
},
"localname": "DocumentTransitionReport",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentType": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
"label": "Document Type",
"terseLabel": "Document Type"
}
}
},
"localname": "DocumentType",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "submissionTypeItemType"
},
"dei_EntityAddressAddressLine1": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Address Line 1 such as Attn, Building Name, Street Name",
"label": "Entity Address, Address Line One",
"terseLabel": "Entity Address, Address Line One"
}
}
},
"localname": "EntityAddressAddressLine1",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressCityOrTown": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the City or Town",
"label": "Entity Address, City or Town",
"terseLabel": "Entity Address, City or Town"
}
}
},
"localname": "EntityAddressCityOrTown",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressPostalZipCode": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Code for the postal or zip code",
"label": "Entity Address, Postal Zip Code",
"terseLabel": "Entity Address, Postal Zip Code"
}
}
},
"localname": "EntityAddressPostalZipCode",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressStateOrProvince": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the state or province.",
"label": "Entity Address, State or Province",
"terseLabel": "Entity Address, State or Province"
}
}
},
"localname": "EntityAddressStateOrProvince",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "stateOrProvinceItemType"
},
"dei_EntityCentralIndexKey": {
"auth_ref": [
"r405"
],
"lang": {
"en-US": {
"role": {
"documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
"label": "Entity Central Index Key",
"terseLabel": "Entity Central Index Key"
}
}
},
"localname": "EntityCentralIndexKey",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "centralIndexKeyItemType"
},
"dei_EntityCommonStockSharesOutstanding": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
"label": "Entity Common Stock, Shares Outstanding",
"terseLabel": "Entity Common Stock, Shares Outstanding"
}
}
},
"localname": "EntityCommonStockSharesOutstanding",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "sharesItemType"
},
"dei_EntityCurrentReportingStatus": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity Current Reporting Status",
"terseLabel": "Entity Current Reporting Status"
}
}
},
"localname": "EntityCurrentReportingStatus",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityEmergingGrowthCompany": {
"auth_ref": [
"r405"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate if registrant meets the emerging growth company criteria.",
"label": "Entity Emerging Growth Company",
"terseLabel": "Entity Emerging Growth Company"
}
}
},
"localname": "EntityEmergingGrowthCompany",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_EntityFileNumber": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
"label": "Entity File Number",
"terseLabel": "Entity File Number"
}
}
},
"localname": "EntityFileNumber",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "fileNumberItemType"
},
"dei_EntityFilerCategory": {
"auth_ref": [
"r405"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity Filer Category",
"terseLabel": "Entity Filer Category"
}
}
},
"localname": "EntityFilerCategory",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "filerCategoryItemType"
},
"dei_EntityIncorporationStateCountryCode": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Two-character EDGAR code representing the state or country of incorporation.",
"label": "Entity Incorporation, State or Country Code",
"terseLabel": "State or Other Jurisdiction of Incorporation or Organization"
}
}
},
"localname": "EntityIncorporationStateCountryCode",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "edgarStateCountryItemType"
},
"dei_EntityInteractiveDataCurrent": {
"auth_ref": [
"r406"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
"label": "Entity Interactive Data Current",
"terseLabel": "Entity Interactive Data Current"
}
}
},
"localname": "EntityInteractiveDataCurrent",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityRegistrantName": {
"auth_ref": [
"r405"
],
"lang": {
"en-US": {
"role": {
"documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
"label": "Entity Registrant Name",
"terseLabel": "Entity Registrant Name"
}
}
},
"localname": "EntityRegistrantName",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityShellCompany": {
"auth_ref": [
"r405"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
"label": "Entity Shell Company",
"terseLabel": "Entity Shell Company"
}
}
},
"localname": "EntityShellCompany",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_EntitySmallBusiness": {
"auth_ref": [
"r405"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
"label": "Entity Small Business",
"terseLabel": "Entity Small Business"
}
}
},
"localname": "EntitySmallBusiness",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_EntityTaxIdentificationNumber": {
"auth_ref": [
"r405"
],
"lang": {
"en-US": {
"role": {
"documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
"label": "Entity Tax Identification Number",
"terseLabel": "I.R.S. Employer Identification No."
}
}
},
"localname": "EntityTaxIdentificationNumber",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "employerIdItemType"
},
"dei_LocalPhoneNumber": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Local phone number for entity.",
"label": "Local Phone Number",
"terseLabel": "Local Phone Number"
}
}
},
"localname": "LocalPhoneNumber",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_Security12bTitle": {
"auth_ref": [
"r401"
],
"lang": {
"en-US": {
"role": {
"documentation": "Title of a 12(b) registered security.",
"label": "Title of 12(b) Security",
"terseLabel": "Title of each class"
}
}
},
"localname": "Security12bTitle",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "securityTitleItemType"
},
"dei_SecurityExchangeName": {
"auth_ref": [
"r402"
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the Exchange on which a security is registered.",
"label": "Security Exchange Name",
"terseLabel": "Security Exchange Name"
}
}
},
"localname": "SecurityExchangeName",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "edgarExchangeCodeItemType"
},
"dei_TradingSymbol": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Trading symbol of an instrument as listed on an exchange.",
"label": "Trading Symbol",
"terseLabel": "Trading Symbol(s)"
}
}
},
"localname": "TradingSymbol",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CoverPage"
],
"xbrltype": "tradingSymbolItemType"
},
"isrg_A2010IncentiveAwardPlanMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "2010 Incentive Award Plan",
"label": "2010 Incentive Award Plan [Member]",
"terseLabel": "2010 Incentive Award Plan"
}
}
},
"localname": "A2010IncentiveAwardPlanMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
],
"xbrltype": "domainItemType"
},
"isrg_AccelerateShareRepurchaseProgramMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Accelerate Share Repurchase Program [Member]",
"label": "Accelerate Share Repurchase Program [Member]",
"terseLabel": "ASR Program"
}
}
},
"localname": "AccelerateShareRepurchaseProgramMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "domainItemType"
},
"isrg_AccountsReceivableExtendedPayment": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Accounts Receivable, Extended Payment",
"label": "Accounts Receivable, Extended Payment",
"terseLabel": "Extended payment terms for trade receivables"
}
}
},
"localname": "AccountsReceivableExtendedPayment",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_AccountsReceivableExtendedPaymentOtherwiseDueInNextQuarter": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Accounts Receivable, Extended Payment, Otherwise Due in Next Quarter",
"label": "Accounts Receivable, Extended Payment, Otherwise Due in Next Quarter",
"terseLabel": "Extended payment terms for trade receivables that would have been due in next quarter"
}
}
},
"localname": "AccountsReceivableExtendedPaymentOtherwiseDueInNextQuarter",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated Other Comprehensive Income (Loss), Available-For-Sale Securities Adjustment, Net of Tax [Abstract]",
"label": "Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax [Abstract]",
"terseLabel": "Unrealized Gains (Losses)\u00a0on Available-for-Sale Securities"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "stringItemType"
},
"isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax [Abstract]",
"label": "Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax [Abstract]",
"terseLabel": "Gains\u00a0(Losses) on\u00a0Hedge Instruments"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "stringItemType"
},
"isrg_AccumulatedOtherComprehensiveIncomeRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated Other Comprehensive Income [Roll Forward]",
"label": "Accumulated Other Comprehensive Income [Roll Forward]",
"terseLabel": "Accumulated Other Comprehensive Income [Roll Forward]"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeRollForward",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "stringItemType"
},
"isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Available For Sale Securities Debt Maturities Fair Value Total",
"label": "Available For Sale Securities Debt Maturities Fair Value Total",
"totalLabel": "Total"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Business Combination, Consideration Transferred, Present Value of Future Cash Payments",
"label": "Business Combination, Consideration Transferred, Present Value of Future Cash Payments",
"terseLabel": "Deferred payments and contingent consideration related to business combinations"
}
}
},
"localname": "BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails",
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Expense",
"label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Expense",
"terseLabel": "Net additional expense"
}
}
},
"localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Business Combination, Contingent Consideration Arrangements, Change in Undiscounted Expected Outcome",
"label": "Business Combination, Contingent Consideration Arrangements, Change in Undiscounted Expected Outcome",
"terseLabel": "Decrease in undiscounted expected contingent liability"
}
}
},
"localname": "BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Business Combination, Contingent Consideration Arrangements, Undiscounted Expected Outcome",
"label": "Business Combination, Contingent Consideration Arrangements, Undiscounted Expected Outcome",
"terseLabel": "Estimated total undiscounted contingent consideration"
}
}
},
"localname": "BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Tangible Assets",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Tangible Assets",
"terseLabel": "Net tangible assets acquired"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
},
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Cash and Cash Equivalents and Debt Securities, Available-for-sale, Amortized Cost",
"label": "Cash and Cash Equivalents and Debt Securities, Available-for-sale, Amortized Cost",
"totalLabel": "Total assets measured at fair value, Amortized Cost"
}
}
},
"localname": "CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
"order": 3.0,
"parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value",
"label": "Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value",
"totalLabel": "Total assets measured at fair value, Fair Value"
}
}
},
"localname": "CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_ChindexMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Chindex [Member]",
"label": "Chindex [Member]",
"terseLabel": "Chindex"
}
}
},
"localname": "ChindexMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "domainItemType"
},
"isrg_CommonStockRepurchaseProgramMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Common Stock Repurchase Program [Member]",
"label": "Common Stock Repurchase Program [Member]",
"terseLabel": "Repurchase Program"
}
}
},
"localname": "CommonStockRepurchaseProgramMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "domainItemType"
},
"isrg_ConsolidatingReportingAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Consolidating Reporting [Axis]",
"label": "Consolidating Reporting [Axis]",
"terseLabel": "Consolidating Reporting [Axis]"
}
}
},
"localname": "ConsolidatingReportingAxis",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
],
"xbrltype": "stringItemType"
},
"isrg_ConsolidatingReportingDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Consolidating Reporting [Domain]",
"label": "Consolidating Reporting [Domain]",
"terseLabel": "Consolidating Reporting [Domain]"
}
}
},
"localname": "ConsolidatingReportingDomain",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
],
"xbrltype": "domainItemType"
},
"isrg_CostOfSalesProductMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Cost Of Sales Product [Member]",
"label": "Cost Of Sales Product [Member]",
"terseLabel": "Cost of sales - products"
}
}
},
"localname": "CostOfSalesProductMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
],
"xbrltype": "domainItemType"
},
"isrg_CostOfSalesServiceMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Cost Of Sales Service [Member]",
"label": "Cost Of Sales Service [Member]",
"terseLabel": "Cost of sales - services"
}
}
},
"localname": "CostOfSalesServiceMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
],
"xbrltype": "domainItemType"
},
"isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Cumulative Effect, Period of Adoption, Adjustment",
"label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
"terseLabel": "Adoption of new accounting standard"
}
}
},
"localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "domainItemType"
},
"isrg_CumulativeEffectPeriodOfAdoptionAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Cumulative Effect, Period of Adoption",
"label": "Cumulative Effect, Period of Adoption [Axis]",
"terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
}
}
},
"localname": "CumulativeEffectPeriodOfAdoptionAxis",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "stringItemType"
},
"isrg_CumulativeEffectPeriodOfAdoptionDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Cumulative Effect, Period of Adoption",
"label": "Cumulative Effect, Period of Adoption [Domain]",
"terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
}
}
},
"localname": "CumulativeEffectPeriodOfAdoptionDomain",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "domainItemType"
},
"isrg_DeferredPurchaseConsiderationPayments": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Deferred Purchase Consideration Payments",
"label": "Deferred Purchase Consideration Payments",
"terseLabel": "Deferred cash payments"
}
}
},
"localname": "DeferredPurchaseConsiderationPayments",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_DeferredPurchaseConsiderationPaymentsCurrent": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails": {
"order": 4.0,
"parentTag": "us-gaap_OtherLiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Deferred Purchase Consideration Payments, Current",
"label": "Deferred Purchase Consideration Payments, Current",
"terseLabel": "Current portion of deferred purchase consideration payments"
}
}
},
"localname": "DeferredPurchaseConsiderationPaymentsCurrent",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Equity Securities, FV-NI, Sales, Purchases and Other Adjustments",
"label": "Equity Securities, FV-NI, Sales, Purchases and Other Adjustments",
"terseLabel": "Sales/Purchases/Others"
}
}
},
"localname": "EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Equity Securities without Readily Determinable Fair Value, Sales, Purchases and Other Adjustments",
"label": "Equity Securities without Readily Determinable Fair Value, Sales, Purchases and Other Adjustments",
"terseLabel": "Sales/Purchases/Others"
}
}
},
"localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss)",
"label": "Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss)",
"terseLabel": "Changes in Fair Value"
}
}
},
"localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
"order": 6.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Finite-Lived Intangible Assets, Amortization Expense, after Year Four",
"label": "Finite-Lived Intangible Assets, Amortization Expense, after Year Four",
"terseLabel": "2025 and thereafter"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_GoldmanSachsCo.Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Goldman, Sachs & Co. [Member]",
"label": "Goldman, Sachs & Co. [Member]",
"terseLabel": "Goldman"
}
}
},
"localname": "GoldmanSachsCo.Member",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "domainItemType"
},
"isrg_HighMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "High",
"label": "High [Member]",
"terseLabel": "High"
}
}
},
"localname": "HighMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "domainItemType"
},
"isrg_InstrumentsandAccessoriesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Instruments and Accessories [Member]",
"label": "Instruments and Accessories [Member]",
"terseLabel": "Instruments and accessories"
}
}
},
"localname": "InstrumentsandAccessoriesMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
],
"xbrltype": "domainItemType"
},
"isrg_IntangibleAndOtherAssets": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 5.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges and other non-current assets.",
"label": "Intangible And Other Assets",
"terseLabel": "Intangible and other assets, net"
}
}
},
"localname": "IntangibleAndOtherAssets",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"isrg_IntangibleAndOtherAssetsNetMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Intangible and Other Assets, Net",
"label": "Intangible and Other Assets, Net [Member]",
"terseLabel": "Intangible and other assets, net"
}
}
},
"localname": "IntangibleAndOtherAssetsNetMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
],
"xbrltype": "domainItemType"
},
"isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Lessor, Sales-type Lease, Lease Income",
"label": "Lessor, Sales-type Lease, Lease Income [Table Text Block]",
"terseLabel": "Schedule of Lease Receivables"
}
}
},
"localname": "LessorSalesTypeLeaseLeaseIncomeTableTextBlock",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESTables"
],
"xbrltype": "textBlockItemType"
},
"isrg_LowMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Low",
"label": "Low [Member]",
"terseLabel": "Low"
}
}
},
"localname": "LowMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "domainItemType"
},
"isrg_ManufacturingProcessTechnologyMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Manufacturing Process Technology",
"label": "Manufacturing Process Technology [Member]",
"terseLabel": "Manufacturing process technology"
}
}
},
"localname": "ManufacturingProcessTechnologyMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "domainItemType"
},
"isrg_ModerateMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Moderate",
"label": "Moderate [Member]",
"terseLabel": "Moderate"
}
}
},
"localname": "ModerateMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "domainItemType"
},
"isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
"order": 1.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Other Comprehensive Income (Loss), Before Reclassification Adjustments, Net of Tax",
"label": "Other Comprehensive Income Loss Before Reclassification Adjustments Net Of Tax",
"terseLabel": "Other comprehensive income (loss) before reclassifications"
}
}
},
"localname": "OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_ResearchAndDevelopmentMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Research And Development [Member]",
"label": "Research And Development [Member]",
"terseLabel": "Research and development"
}
}
},
"localname": "ResearchAndDevelopmentMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
],
"xbrltype": "domainItemType"
},
"isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
"order": 6.0,
"parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Year Five and Thereafter",
"label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Year Five and Thereafter",
"terseLabel": "2025 and thereafter"
}
}
},
"localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_SalesTypeLeaseGrossInvestmentInLease": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1": {
"order": 2.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sales-type Lease, Gross Investment in Lease",
"label": "Sales-type Lease, Gross Investment in Lease",
"terseLabel": "Gross lease receivables"
}
}
},
"localname": "SalesTypeLeaseGrossInvestmentInLease",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_SalesTypeLeaseLeaseReceivableExtendedPayment": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sales-type Lease, Lease Receivable, Extended Payment",
"label": "Sales-type Lease, Lease Receivable, Extended Payment",
"terseLabel": "Extended payment terms for lease billings"
}
}
},
"localname": "SalesTypeLeaseLeaseReceivableExtendedPayment",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails": {
"order": 3.0,
"parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sales-type Lease, Net Investment in Lease, Current",
"label": "Sales-type Lease, Net Investment in Lease, Current",
"verboseLabel": "Net investment in sales-type leases \u2013 short-term"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseCurrent",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYearAllowanceForCreditLossWriteoff": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails": {
"order": 4.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLossWriteoff",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sales-type Lease, Net Investment in Lease, Originated Five or More Years before Latest Fiscal Year, Allowance for Credit Loss, Writeoff",
"label": "Sales-type Lease, Net Investment in Lease, Originated Five or More Years before Latest Fiscal Year, Allowance for Credit Loss, Writeoff",
"terseLabel": "Current-period net write-offs, Prior"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYearAllowanceForCreditLossWriteoff",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYearAllowanceForCreditLossWriteoff": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails": {
"order": 6.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLossWriteoff",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sales-type Lease, Net Investment in Lease, Originated Four Years before Latest Fiscal Year, Allowance for Credit Loss, Writeoff",
"label": "Sales-type Lease, Net Investment in Lease, Originated Four Years before Latest Fiscal Year, Allowance for Credit Loss, Writeoff",
"terseLabel": "Current-period net write-offs, 2016"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYearAllowanceForCreditLossWriteoff",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYearAllowanceForCreditLossWriteoff": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails": {
"order": 1.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLossWriteoff",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sales-type Lease, Net Investment in Lease, Originated in Current Fiscal Year, Allowance for Credit Loss, Writeoff",
"label": "Sales-type Lease, Net Investment in Lease, Originated in Current Fiscal Year, Allowance for Credit Loss, Writeoff",
"terseLabel": "Current-period net write-offs, 2020"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYearAllowanceForCreditLossWriteoff",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYearAllowanceForCreditLossWriteoff": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails": {
"order": 2.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLossWriteoff",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sales-type Lease, Net Investment in Lease, Originated in Fiscal Year before Latest Fiscal Year, Allowance for Credit Loss, Writeoff",
"label": "Sales-type Lease, Net Investment in Lease, Originated in Fiscal Year before Latest Fiscal Year, Allowance for Credit Loss, Writeoff",
"terseLabel": "Current-period net write-offs, 2019"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYearAllowanceForCreditLossWriteoff",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYearAllowanceForCreditLossWriteoff": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails": {
"order": 3.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLossWriteoff",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sales-type Lease, Net Investment in Lease, Originated Three Years before Latest Fiscal Year, Allowance for Credit Loss, Writeoff",
"label": "Sales-type Lease, Net Investment in Lease, Originated Three Years before Latest Fiscal Year, Allowance for Credit Loss, Writeoff",
"terseLabel": "Current-period net write-offs, 2017"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYearAllowanceForCreditLossWriteoff",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYearAllowanceForCreditLossWriteoff": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails": {
"order": 5.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLossWriteoff",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sales-type Lease, Net Investment in Lease, Originated Two Years before Latest Fiscal Year, Allowance for Credit Loss, Writeoff",
"label": "Sales-type Lease, Net Investment in Lease, Originated Two Years before Latest Fiscal Year, Allowance for Credit Loss, Writeoff",
"terseLabel": "Current-period net write-offs, 2018f"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYearAllowanceForCreditLossWriteoff",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_SalestypeLeaseDeferredSellingProfit": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1": {
"order": 1.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Sales-type Lease, Deferred Selling Profit",
"label": "Sales-type Lease, Deferred Selling Profit",
"negatedLabel": "Unearned income"
}
}
},
"localname": "SalestypeLeaseDeferredSellingProfit",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_SchllyFiberopticGmbHMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Sch\u00f6lly Fiberoptic GmbH [Member]",
"label": "Sch\u00f6lly Fiberoptic GmbH [Member]",
"terseLabel": "Sch\u00f6lly"
}
}
},
"localname": "SchllyFiberopticGmbHMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "domainItemType"
},
"isrg_SellingGeneralAndAdministrativeMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Costs related to selling, general and administrative activities.",
"label": "Selling General And Administrative [Member]",
"terseLabel": "Selling, general and administrative"
}
}
},
"localname": "SellingGeneralAndAdministrativeMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
],
"xbrltype": "domainItemType"
},
"isrg_ServiceFeeCredit": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Service Fee Credit",
"label": "Service Fee Credit",
"terseLabel": "Service fee credits"
}
}
},
"localname": "ServiceFeeCredit",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_ServicesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Services [Member]",
"label": "Services [Member]",
"terseLabel": "Services"
}
}
},
"localname": "ServicesMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
],
"xbrltype": "domainItemType"
},
"isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]",
"label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Exercise Price [Abstract]",
"terseLabel": "Weighted\u00a0Average Exercise\u00a0Price Per Share"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
],
"xbrltype": "stringItemType"
},
"isrg_StockRepurchaseProgramincreasedtoauthorizedamount": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Increased to authorized shares repurchase amount for Stock Repurchase Program",
"label": "Stock Repurchase Program, increased to authorized amount",
"terseLabel": "Stock repurchase program, increased to authorized amount"
}
}
},
"localname": "StockRepurchaseProgramincreasedtoauthorizedamount",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "monetaryItemType"
},
"isrg_SystemsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Systems [Member]",
"label": "Systems [Member]",
"terseLabel": "Systems"
}
}
},
"localname": "SystemsMember",
"nsuri": "http://www.intuitivesurgical.com/20200930",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
],
"xbrltype": "domainItemType"
},
"srt_CounterpartyNameAxis": {
"auth_ref": [
"r52",
"r101"
],
"lang": {
"en-US": {
"role": {
"label": "Counterparty Name [Axis]",
"terseLabel": "Counterparty Name [Axis]"
}
}
},
"localname": "CounterpartyNameAxis",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "stringItemType"
},
"srt_MaximumMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Maximum [Member]",
"terseLabel": "Maximum"
}
}
},
"localname": "MaximumMember",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
],
"xbrltype": "domainItemType"
},
"srt_MinimumMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Minimum [Member]",
"terseLabel": "Minimum"
}
}
},
"localname": "MinimumMember",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
],
"xbrltype": "domainItemType"
},
"srt_ProductOrServiceAxis": {
"auth_ref": [
"r125",
"r233",
"r236",
"r397",
"r398"
],
"lang": {
"en-US": {
"role": {
"label": "Product and Service [Axis]",
"terseLabel": "Product and Service [Axis]"
}
}
},
"localname": "ProductOrServiceAxis",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
],
"xbrltype": "stringItemType"
},
"srt_ProductsAndServicesDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Product and Service [Domain]",
"terseLabel": "Product and Service [Domain]"
}
}
},
"localname": "ProductsAndServicesDomain",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
],
"xbrltype": "domainItemType"
},
"srt_RangeAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statistical Measurement [Axis]",
"terseLabel": "Statistical Measurement [Axis]"
}
}
},
"localname": "RangeAxis",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
],
"xbrltype": "stringItemType"
},
"srt_RangeMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statistical Measurement [Domain]",
"terseLabel": "Statistical Measurement [Domain]"
}
}
},
"localname": "RangeMember",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
],
"xbrltype": "domainItemType"
},
"srt_RepurchaseAgreementCounterpartyNameDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Counterparty Name [Domain]",
"terseLabel": "Counterparty Name [Domain]"
}
}
},
"localname": "RepurchaseAgreementCounterpartyNameDomain",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": {
"auth_ref": [
"r219"
],
"lang": {
"en-US": {
"role": {
"documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.",
"label": "Accelerated Share Repurchases, Final Price Paid Per Share",
"terseLabel": "Final average price per share paid (in dollars per share)"
}
}
},
"localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_AccountingPoliciesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Accounting Policies [Abstract]",
"terseLabel": "Accounting Policies [Abstract]"
}
}
},
"localname": "AccountingPoliciesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_AccountsPayableCurrent": {
"auth_ref": [
"r38"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
"label": "Accounts Payable, Current",
"terseLabel": "Accounts payable"
}
}
},
"localname": "AccountsPayableCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccountsReceivableNetCurrent": {
"auth_ref": [
"r2",
"r20",
"r126",
"r127",
"r234"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
"label": "Accounts Receivable, after Allowance for Credit Loss, Current",
"terseLabel": "Accounts receivable, net"
}
}
},
"localname": "AccountsReceivableNetCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
"auth_ref": [
"r95"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
"label": "Accretion (Amortization) of Discounts and Premiums, Investments",
"negatedLabel": "Loss (gain) on investments, accretion, and amortization, net"
}
}
},
"localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccruedIncomeTaxesNoncurrent": {
"auth_ref": [
"r17",
"r376",
"r388"
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails": {
"order": 1.0,
"parentTag": "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
"label": "Accrued Income Taxes, Noncurrent",
"terseLabel": "Income taxes\u2014long-term"
}
}
},
"localname": "AccruedIncomeTaxesNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
"auth_ref": [
"r61"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
"label": "AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax",
"periodEndLabel": "Ending balance",
"periodStartLabel": "Beginning balance"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax": {
"auth_ref": [
"r55",
"r60",
"r61"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.",
"label": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax",
"periodEndLabel": "Ending balance",
"periodStartLabel": "Beginning balance"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
"auth_ref": [
"r58",
"r62"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
"label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
"periodEndLabel": "Ending balance",
"periodStartLabel": "Beginning balance"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
"auth_ref": [
"r53",
"r60",
"r61",
"r62",
"r350",
"r355",
"r360"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
"label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
"periodEndLabel": "Ending balance",
"periodStartLabel": "Beginning balance"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
"auth_ref": [
"r60",
"r61",
"r62"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 5.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
"label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
"periodEndLabel": "Ending balance",
"periodStartLabel": "Beginning balance",
"terseLabel": "Accumulated other comprehensive income (loss)"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
"terseLabel": "Total"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
"auth_ref": [
"r59",
"r62",
"r66",
"r314"
],
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
"label": "AOCI Attributable to Parent [Member]",
"terseLabel": "Accumulated Other Comprehensive Income (Loss)"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
"auth_ref": [
"r190"
],
"lang": {
"en-US": {
"role": {
"documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
"label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
"terseLabel": "Weighted average useful life"
}
}
},
"localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "durationItemType"
},
"us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
"label": "Additional Financial Information Disclosure [Text Block]",
"terseLabel": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION"
}
}
},
"localname": "AdditionalFinancialInformationDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_AdditionalPaidInCapitalCommonStock": {
"auth_ref": [
"r21"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
"label": "Additional Paid in Capital, Common Stock",
"terseLabel": "Additional paid-in capital"
}
}
},
"localname": "AdditionalPaidInCapitalCommonStock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdditionalPaidInCapitalMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
"label": "Additional Paid-in Capital [Member]",
"terseLabel": "Additional Paid-In Capital"
}
}
},
"localname": "AdditionalPaidInCapitalMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
"label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
"negatedTerseLabel": "Shares withheld related to net share settlement of equity awards"
}
}
},
"localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
"auth_ref": [
"r242",
"r244",
"r271",
"r272"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
"label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
"terseLabel": "Share-based compensation expense related to employee stock plans"
}
}
},
"localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
"terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
}
}
},
"localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_AllocatedShareBasedCompensationExpense": {
"auth_ref": [
"r244",
"r267",
"r270"
],
"calculation": {
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails": {
"order": 1.0,
"parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
"label": "Share-based Payment Arrangement, Expense",
"terseLabel": "Share-based compensation expense before income taxes"
}
}
},
"localname": "AllocatedShareBasedCompensationExpense",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
"label": "Share-based Payment Arrangement, Expense, after Tax",
"totalLabel": "Share-based compensation expense after income taxes"
}
}
},
"localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AmortizationOfIntangibleAssets": {
"auth_ref": [
"r94",
"r187",
"r194"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
"label": "Amortization of Intangible Assets",
"terseLabel": "Amortization of intangible assets"
}
}
},
"localname": "AmortizationOfIntangibleAssets",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
"auth_ref": [
"r115"
],
"lang": {
"en-US": {
"role": {
"documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
"label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
"terseLabel": "Employee stock options excluded from computation of diluted net income per share"
}
}
},
"localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_Assets": {
"auth_ref": [
"r123",
"r375",
"r387"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets",
"totalLabel": "Total assets"
}
}
},
"localname": "Assets",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Assets [Abstract]",
"terseLabel": "ASSETS"
}
}
},
"localname": "AssetsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_AssetsCurrent": {
"auth_ref": [
"r6",
"r8",
"r51"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets, Current",
"totalLabel": "Total current assets"
}
}
},
"localname": "AssetsCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Assets, Current [Abstract]",
"terseLabel": "Current assets:"
}
}
},
"localname": "AssetsCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
"auth_ref": [
"r135"
],
"calculation": {
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
"order": 1.0,
"parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
"label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
"terseLabel": "Gross Unrealized Gains"
}
}
},
"localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
"auth_ref": [
"r136"
],
"calculation": {
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
"order": 2.0,
"parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
"label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
"negatedLabel": "Gross Unrealized Losses"
}
}
},
"localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
"auth_ref": [
"r132",
"r164"
],
"calculation": {
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
},
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1": {
"order": 1.0,
"parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
"weight": 1.0
},
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
"label": "Debt Securities, Available-for-sale, Amortized Cost",
"totalLabel": "Total"
}
}
},
"localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
"auth_ref": [
"r140"
],
"calculation": {
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
"order": 2.0,
"parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
"label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost",
"terseLabel": "Mature in one to five years"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
"auth_ref": [
"r137",
"r140",
"r385"
],
"calculation": {
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
"order": 2.0,
"parentTag": "isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
"label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value",
"terseLabel": "Mature in one to five years"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
"terseLabel": "Amortized Cost"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]",
"terseLabel": "Fair Value"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
"auth_ref": [
"r139"
],
"calculation": {
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
"order": 1.0,
"parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amortized cost of investment in debt security measured at fair value with change recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
"label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost",
"terseLabel": "Mature in less than one year"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
"auth_ref": [
"r137",
"r139",
"r384"
],
"calculation": {
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
"order": 1.0,
"parentTag": "isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
"label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value",
"terseLabel": "Mature in less than one year"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
"auth_ref": [
"r130",
"r133",
"r164"
],
"calculation": {
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
"order": 3.0,
"parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
"label": "Debt Securities, Available-for-sale",
"terseLabel": "Fair Value"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtSecurities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
"label": "Available-for-sale Securities [Table Text Block]",
"terseLabel": "Summary of Cash and Available-For-Sale Securities"
}
}
},
"localname": "AvailableForSaleSecuritiesTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_AwardTypeAxis": {
"auth_ref": [
"r246",
"r268"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of award under share-based payment arrangement.",
"label": "Award Type [Axis]",
"terseLabel": "Award Type [Axis]",
"verboseLabel": "Award Type [Axis]"
}
}
},
"localname": "AwardTypeAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails",
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_BalanceSheetLocationAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by location on balance sheet (statement of financial position).",
"label": "Balance Sheet Location [Axis]",
"terseLabel": "Balance Sheet Location [Axis]"
}
}
},
"localname": "BalanceSheetLocationAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails",
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_BalanceSheetLocationDomain": {
"auth_ref": [
"r328",
"r332"
],
"lang": {
"en-US": {
"role": {
"documentation": "Location in the balance sheet (statement of financial position).",
"label": "Balance Sheet Location [Domain]",
"terseLabel": "Balance Sheet Location [Domain]"
}
}
},
"localname": "BalanceSheetLocationDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails",
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
"label": "Basis of Accounting, Policy [Policy Text Block]",
"terseLabel": "Basis of Presentation"
}
}
},
"localname": "BasisOfAccountingPolicyPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_BusinessAcquisitionAcquireeDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
"label": "Business Acquisition, Acquiree [Domain]",
"terseLabel": "Business Acquisition, Acquiree [Domain]"
}
}
},
"localname": "BusinessAcquisitionAcquireeDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_BusinessAcquisitionAxis": {
"auth_ref": [
"r292",
"r293"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by business combination or series of individually immaterial business combinations.",
"label": "Business Acquisition [Axis]",
"terseLabel": "Business Acquisition [Axis]"
}
}
},
"localname": "BusinessAcquisitionAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_BusinessAcquisitionLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Business Acquisition [Line Items]",
"terseLabel": "Business Acquisition [Line Items]"
}
}
},
"localname": "BusinessAcquisitionLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_BusinessCombinationConsiderationTransferred1": {
"auth_ref": [
"r300",
"r301",
"r303"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
"label": "Business Combination, Consideration Transferred",
"terseLabel": "Total purchase consideration"
}
}
},
"localname": "BusinessCombinationConsiderationTransferred1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
"auth_ref": [
"r299",
"r302"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
"label": "Business Combination, Contingent Consideration, Liability, Current",
"terseLabel": "Business Combination, Contingent Consideration, Liability, Current"
}
}
},
"localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
"auth_ref": [
"r295"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
"terseLabel": "Cash"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
"auth_ref": [
"r295"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
"terseLabel": "Intangible assets acquired"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
"auth_ref": [
"r294",
"r295"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of inventory recognized as of the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
"terseLabel": "Inventory"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalLeasedAssetsLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Capital Leased Assets [Line Items]",
"terseLabel": "Capital Leased Assets [Line Items]"
}
}
},
"localname": "CapitalLeasedAssetsLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock": {
"auth_ref": [
"r362"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for lessor's leasing arrangements, which includes direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.",
"label": "Capital Leases in Financial Statements of Lessor Disclosure [Text Block]",
"terseLabel": "Schedule of Lease Receivables"
}
}
},
"localname": "CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_CapitalizedContractCostAmortization": {
"auth_ref": [
"r179"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 7.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.",
"label": "Capitalized Contract Cost, Amortization",
"terseLabel": "Amortization of contract acquisition assets"
}
}
},
"localname": "CapitalizedContractCostAmortization",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalizedContractCostNet": {
"auth_ref": [
"r178"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
"label": "Capitalized Contract Cost, Net",
"terseLabel": "Costs capitalized as contract acquisition costs"
}
}
},
"localname": "CapitalizedContractCostNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashAndCashEquivalentsAtCarryingValue": {
"auth_ref": [
"r0",
"r35",
"r96"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
},
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1": {
"order": 2.0,
"parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
"label": "Cash and Cash Equivalents, at Carrying Value",
"terseLabel": "Cash and cash equivalents"
}
}
},
"localname": "CashAndCashEquivalentsAtCarryingValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
"order": 1.0,
"parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Cash and Cash Equivalents, Fair Value Disclosure",
"terseLabel": "Fair Value"
}
}
},
"localname": "CashAndCashEquivalentsFairValueDisclosure",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
"auth_ref": [
"r91",
"r96",
"r97"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
"periodEndLabel": "Cash, cash equivalents, and restricted cash, end of period",
"periodStartLabel": "Cash, cash equivalents, and restricted cash, beginning of period"
}
}
},
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
"auth_ref": [
"r91",
"r354"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
"totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash"
}
}
},
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashMember": {
"auth_ref": [
"r14"
],
"lang": {
"en-US": {
"role": {
"documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
"label": "Cash [Member]",
"terseLabel": "Cash"
}
}
},
"localname": "CashMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ClassOfStockLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Class of Stock [Line Items]",
"terseLabel": "Class of Stock [Line Items]"
}
}
},
"localname": "ClassOfStockLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ClassOfTreasuryStockTable": {
"auth_ref": [
"r220",
"r221",
"r222",
"r223"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
"label": "Class of Treasury Stock [Table]",
"terseLabel": "Class of Treasury Stock [Table]"
}
}
},
"localname": "ClassOfTreasuryStockTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_CommercialPaperMember": {
"auth_ref": [
"r207"
],
"lang": {
"en-US": {
"role": {
"documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
"label": "Commercial Paper [Member]",
"terseLabel": "Commercial paper"
}
}
},
"localname": "CommercialPaperMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_CommitmentsAndContingencies": {
"auth_ref": [
"r45",
"r203",
"r380",
"r393"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
"label": "Commitments and Contingencies",
"terseLabel": "Contingencies (Note 8)"
}
}
},
"localname": "CommitmentsAndContingencies",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Commitments and Contingencies Disclosure [Abstract]",
"terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
}
}
},
"localname": "CommitmentsAndContingenciesDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
"auth_ref": [
"r202",
"r205"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for commitments and contingencies.",
"label": "Commitments and Contingencies Disclosure [Text Block]",
"terseLabel": "CONTINGENCIES"
}
}
},
"localname": "CommitmentsAndContingenciesDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CONTINGENCIES"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
"auth_ref": [
"r47"
],
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate number of common shares reserved for future issuance.",
"label": "Common Stock, Capital Shares Reserved for Future Issuance",
"terseLabel": "Number of shares reserved for future issuance"
}
}
},
"localname": "CommonStockCapitalSharesReservedForFutureIssuance",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Stock that is subordinate to all other stock of the issuer.",
"label": "Common Stock [Member]",
"terseLabel": "Common Stock"
}
}
},
"localname": "CommonStockMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_CommonStockParOrStatedValuePerShare": {
"auth_ref": [
"r19"
],
"lang": {
"en-US": {
"role": {
"documentation": "Face amount or stated value per share of common stock.",
"label": "Common Stock, Par or Stated Value Per Share",
"terseLabel": "Common stock, par value (in dollars per share)"
}
}
},
"localname": "CommonStockParOrStatedValuePerShare",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "perShareItemType"
},
"us-gaap_CommonStockSharesAuthorized": {
"auth_ref": [
"r19"
],
"lang": {
"en-US": {
"role": {
"documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
"label": "Common Stock, Shares Authorized",
"terseLabel": "Common stock, shares authorized (in shares)"
}
}
},
"localname": "CommonStockSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockSharesIssued": {
"auth_ref": [
"r19"
],
"lang": {
"en-US": {
"role": {
"documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
"label": "Common Stock, Shares, Issued",
"terseLabel": "Common stock, shares issued (in shares)"
}
}
},
"localname": "CommonStockSharesIssued",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockSharesOutstanding": {
"auth_ref": [
"r19",
"r211"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
"label": "Common Stock, Shares, Outstanding",
"periodEndLabel": "Ending balance (in shares)",
"periodStartLabel": "Beginning balance (in shares)",
"terseLabel": "Common stock, shares outstanding (in shares)"
}
}
},
"localname": "CommonStockSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockValue": {
"auth_ref": [
"r19"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
"label": "Common Stock, Value, Issued",
"terseLabel": "Common stock, 300.0 shares authorized, $0.001 par value, 117.0 shares and 116.0 shares issued and outstanding as of June 30, 2020, and December 31, 2019, respectively"
}
}
},
"localname": "CommonStockValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ComprehensiveIncomeNetOfTax": {
"auth_ref": [
"r69",
"r71",
"r72"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
"label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
"terseLabel": "Total comprehensive income attributable to Intuitive Surgical, Inc."
}
}
},
"localname": "ComprehensiveIncomeNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
"auth_ref": [
"r98",
"r99",
"r309",
"r318",
"r319",
"r320"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
"label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
"terseLabel": "Consolidation and Joint Ventures"
}
}
},
"localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
"auth_ref": [
"r228"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of contract balances and changes in contract balances.",
"label": "Contract with Customer, Asset and Liability [Table Text Block]",
"terseLabel": "Summary of Contract Assets and Liabilities"
}
}
},
"localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ContractWithCustomerAssetNet": {
"auth_ref": [
"r225",
"r227",
"r234"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
"label": "Contract with Customer, Asset, after Allowance for Credit Loss",
"terseLabel": "Contract assets"
}
}
},
"localname": "ContractWithCustomerAssetNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ContractWithCustomerLiability": {
"auth_ref": [
"r225",
"r226",
"r234"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
"label": "Contract with Customer, Liability",
"terseLabel": "Deferred revenue"
}
}
},
"localname": "ContractWithCustomerLiability",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
"auth_ref": [
"r235"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
"label": "Contract with Customer, Liability, Revenue Recognized",
"terseLabel": "Revenue recognized"
}
}
},
"localname": "ContractWithCustomerLiabilityRevenueRecognized",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CorporateDebtSecuritiesMember": {
"auth_ref": [
"r238",
"r241",
"r399"
],
"lang": {
"en-US": {
"role": {
"documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
"label": "Corporate Debt Securities [Member]",
"terseLabel": "Corporate debt securities"
}
}
},
"localname": "CorporateDebtSecuritiesMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_CostOfGoodsAndServicesSold": {
"auth_ref": [
"r77"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_GrossProfit",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
"label": "Cost of Goods and Services Sold",
"terseLabel": "Total cost of revenue"
}
}
},
"localname": "CostOfGoodsAndServicesSold",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CostOfRevenueAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Cost of Revenue [Abstract]",
"terseLabel": "Cost of revenue:"
}
}
},
"localname": "CostOfRevenueAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_CostOfSalesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing cost of sales.",
"label": "Cost of Sales [Member]",
"terseLabel": "Total cost of sales"
}
}
},
"localname": "CostOfSalesMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_CumulativeTranslationAdjustmentSummaryRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
"label": "Cumulative Translation Adjustment Summary [Roll Forward]",
"terseLabel": "Foreign Currency Translation Gains\u00a0(Losses)"
}
}
},
"localname": "CumulativeTranslationAdjustmentSummaryRollForward",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_CustomerRelationshipsMember": {
"auth_ref": [
"r298"
],
"lang": {
"en-US": {
"role": {
"documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
"label": "Customer Relationships [Member]",
"terseLabel": "Customer relationships"
}
}
},
"localname": "CustomerRelationshipsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
"auth_ref": [
"r134",
"r164",
"r169",
"r170"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
"label": "Debt Securities, Available-for-sale, Allowance for Credit Loss",
"terseLabel": "Allowance for Credit Loss"
}
}
},
"localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal": {
"auth_ref": [
"r165",
"r168"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of expense (reversal of expense) for expected credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), from change in present value of expected cash flows.",
"label": "Debt Securities, Available-for-sale, Change in Present Value, Expense (Reversal)",
"terseLabel": "Available-for-sales debt securities credit losses"
}
}
},
"localname": "DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
"auth_ref": [
"r37"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
"label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
"terseLabel": "Prepaids and Other Current Assets"
}
}
},
"localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_DeferredIncomeTaxAssetsNet": {
"auth_ref": [
"r285"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
"label": "Deferred Income Tax Assets, Net",
"terseLabel": "Deferred tax assets"
}
}
},
"localname": "DeferredIncomeTaxAssetsNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredIncomeTaxExpenseBenefit": {
"auth_ref": [
"r94",
"r100",
"r286",
"r288"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 5.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
"label": "Deferred Income Tax Expense (Benefit)",
"terseLabel": "Deferred income taxes"
}
}
},
"localname": "DeferredIncomeTaxExpenseBenefit",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredRevenueCurrent": {
"auth_ref": [
"r26"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
"label": "Deferred Revenue, Current",
"terseLabel": "Deferred revenue"
}
}
},
"localname": "DeferredRevenueCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredRevenueNoncurrent": {
"auth_ref": [
"r26"
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails": {
"order": 2.0,
"parentTag": "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
"label": "Deferred Revenue, Noncurrent",
"terseLabel": "Deferred revenue\u2014long-term"
}
}
},
"localname": "DeferredRevenueNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_Depreciation": {
"auth_ref": [
"r94",
"r198"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
"label": "Depreciation",
"terseLabel": "Depreciation and loss on disposal of property, plant, and equipment"
}
}
},
"localname": "Depreciation",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DerivativeContractTypeDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
"label": "Derivative Contract [Domain]",
"terseLabel": "Derivative Contract [Domain]"
}
}
},
"localname": "DerivativeContractTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DerivativeGainLossOnDerivativeNet": {
"auth_ref": [
"r330"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
"label": "Derivative, Gain (Loss) on Derivative, Net",
"terseLabel": "Recognized gains/(losses) in interest and other income, net"
}
}
},
"localname": "DerivativeGainLossOnDerivativeNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DerivativeInstrumentRiskAxis": {
"auth_ref": [
"r329",
"r331",
"r335",
"r337"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of derivative contract.",
"label": "Derivative Instrument [Axis]",
"terseLabel": "Derivative Instrument [Axis]"
}
}
},
"localname": "DerivativeInstrumentRiskAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DerivativeNotionalAmount": {
"auth_ref": [
"r322",
"r324"
],
"lang": {
"en-US": {
"role": {
"documentation": "Nominal or face amount used to calculate payment on derivative.",
"label": "Derivative, Notional Amount",
"terseLabel": "Notional amounts of outstanding currency forward contracts"
}
}
},
"localname": "DerivativeNotionalAmount",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DesignatedAsHedgingInstrumentMember": {
"auth_ref": [
"r325"
],
"lang": {
"en-US": {
"role": {
"documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
"label": "Designated as Hedging Instrument [Member]",
"terseLabel": "Derivatives Designated as Hedging Instruments"
}
}
},
"localname": "DesignatedAsHedgingInstrumentMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DisaggregationOfRevenueLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Disaggregation of Revenue [Line Items]",
"terseLabel": "Disaggregation of Revenue [Line Items]"
}
}
},
"localname": "DisaggregationOfRevenueLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DisaggregationOfRevenueTable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
"label": "Disaggregation of Revenue [Table]",
"terseLabel": "Disaggregation of Revenue [Table]"
}
}
},
"localname": "DisaggregationOfRevenueTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DisaggregationOfRevenueTableTextBlock": {
"auth_ref": [
"r233"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
"label": "Disaggregation of Revenue [Table Text Block]",
"terseLabel": "Revenue Disaggregated by Types and Geography"
}
}
},
"localname": "DisaggregationOfRevenueTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
"auth_ref": [
"r273"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for share-based payment arrangement.",
"label": "Share-based Payment Arrangement [Text Block]",
"terseLabel": "SHARE-BASED COMPENSATION"
}
}
},
"localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Share-based Payment Arrangement [Abstract]",
"terseLabel": "Share-based Payment Arrangement [Abstract]"
}
}
},
"localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_DistributionRightsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Legal rights, generally of a limited duration, to distribute a product or products, often within specific geographic areas or supply channels.",
"label": "Distribution Rights [Member]",
"terseLabel": "Distribution rights and others"
}
}
},
"localname": "DistributionRightsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_EarningsPerShareAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Earnings Per Share [Abstract]",
"terseLabel": "Net income per share attributable to Intuitive Surgical, Inc.:"
}
}
},
"localname": "EarningsPerShareAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_EarningsPerShareBasic": {
"auth_ref": [
"r75",
"r108",
"r111",
"r112",
"r113",
"r114",
"r117",
"r382",
"r395"
],
"lang": {
"en-US": {
"role": {
"documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
"label": "Earnings Per Share, Basic",
"terseLabel": "Basic (in dollars per share)"
}
}
},
"localname": "EarningsPerShareBasic",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
"http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Earnings Per Share, Basic and Diluted [Abstract]",
"terseLabel": "Net income per share attributable to Intuitive Surgical, Inc.:"
}
}
},
"localname": "EarningsPerShareBasicAndDilutedAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_EarningsPerShareDiluted": {
"auth_ref": [
"r75",
"r108",
"r111",
"r112",
"r113",
"r114",
"r117",
"r382",
"r395"
],
"lang": {
"en-US": {
"role": {
"documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
"label": "Earnings Per Share, Diluted",
"terseLabel": "Diluted (in dollars per share)"
}
}
},
"localname": "EarningsPerShareDiluted",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
"http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_EarningsPerShareTextBlock": {
"auth_ref": [
"r118"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for earnings per share.",
"label": "Earnings Per Share [Text Block]",
"terseLabel": "NET INCOME PER SHARE"
}
}
},
"localname": "EarningsPerShareTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
"auth_ref": [
"r354"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
"label": "Effect of Exchange Rate on Cash and Cash Equivalents",
"terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
}
}
},
"localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
"auth_ref": [
"r104",
"r278",
"r279"
],
"lang": {
"en-US": {
"role": {
"documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
"label": "Effective Income Tax Rate Reconciliation, Percent",
"terseLabel": "Income tax expense, percentage of pre-tax income"
}
}
},
"localname": "EffectiveIncomeTaxRateContinuingOperations",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_EmployeeRelatedLiabilitiesCurrent": {
"auth_ref": [
"r42"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
"label": "Employee-related Liabilities, Current",
"terseLabel": "Accrued compensation and employee benefits"
}
}
},
"localname": "EmployeeRelatedLiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
"terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]"
}
}
},
"localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
"auth_ref": [
"r267"
],
"calculation": {
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails": {
"order": 2.0,
"parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
"label": "Share-based Payment Arrangement, Expense, Tax Benefit",
"terseLabel": "Income tax benefit"
}
}
},
"localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EmployeeStockMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
"label": "Employee Stock [Member]",
"verboseLabel": "ESPP"
}
}
},
"localname": "EmployeeStockMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_EquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Equity [Abstract]",
"terseLabel": "Equity [Abstract]"
}
}
},
"localname": "EquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_EquityClassOfTreasuryStockLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Equity, Class of Treasury Stock [Line Items]",
"terseLabel": "Equity, Class of Treasury Stock [Line Items]"
}
}
},
"localname": "EquityClassOfTreasuryStockLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_EquityComponentDomain": {
"auth_ref": [
"r211"
],
"lang": {
"en-US": {
"role": {
"documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
"label": "Equity Component [Domain]",
"terseLabel": "Equity Component [Domain]"
}
}
},
"localname": "EquityComponentDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_EquitySecuritiesFvNi": {
"auth_ref": [
"r349"
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails": {
"order": 1.0,
"parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
"label": "Equity Securities, FV-NI",
"periodEndLabel": "Equity investments with readily determinable value beginning balance, Carrying Value",
"periodStartLabel": "Equity investments with readily determinable value beginning balance, Carrying Value",
"terseLabel": "Equity investments"
}
}
},
"localname": "EquitySecuritiesFvNi",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
"auth_ref": [
"r148"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
"label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
"terseLabel": "Changes in Fair Value"
}
}
},
"localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
"auth_ref": [
"r147"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of investment in equity security without readily determinable fair value.",
"label": "Equity Securities without Readily Determinable Fair Value, Amount",
"terseLabel": "Equity investments without readily determinable value, Carrying Value"
}
}
},
"localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
"terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
}
}
},
"localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
"auth_ref": [
"r345",
"r346",
"r347",
"r348"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
"label": "Fair Value, Recurring and Nonrecurring [Table]",
"terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
}
}
},
"localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
"label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
"terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
}
}
},
"localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueByFairValueHierarchyLevelAxis": {
"auth_ref": [
"r238",
"r239",
"r241",
"r346",
"r370"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
"label": "Fair Value Hierarchy and NAV [Axis]",
"terseLabel": "Fair Value, Hierarchy"
}
}
},
"localname": "FairValueByFairValueHierarchyLevelAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueDisclosuresAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Fair Value Disclosures [Abstract]"
}
}
},
"localname": "FairValueDisclosuresAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_FairValueInputsLevel1Member": {
"auth_ref": [
"r238",
"r239",
"r241",
"r346",
"r371"
],
"lang": {
"en-US": {
"role": {
"documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
"label": "Fair Value, Inputs, Level 1 [Member]",
"terseLabel": "Level 1"
}
}
},
"localname": "FairValueInputsLevel1Member",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueInputsLevel2Member": {
"auth_ref": [
"r238",
"r239",
"r241",
"r346",
"r372"
],
"lang": {
"en-US": {
"role": {
"documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
"label": "Fair Value, Inputs, Level 2 [Member]",
"terseLabel": "Level 2"
}
}
},
"localname": "FairValueInputsLevel2Member",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
"label": "Fair Value Hierarchy and NAV [Domain]",
"terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
}
}
},
"localname": "FairValueMeasurementsFairValueHierarchyDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FinancialInstrumentAxis": {
"auth_ref": [
"r150",
"r154",
"r155",
"r156",
"r157",
"r166",
"r167",
"r171",
"r172"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of financial instrument.",
"label": "Financial Instrument [Axis]",
"terseLabel": "Financial Instrument [Axis]"
}
}
},
"localname": "FinancialInstrumentAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FinancialInstrumentsDisclosureTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
"label": "Financial Instruments Disclosure [Text Block]",
"terseLabel": "FINANCIAL INSTRUMENTS"
}
}
},
"localname": "FinancialInstrumentsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock": {
"auth_ref": [
"r128",
"r157"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics.",
"label": "Financing Receivable Credit Quality Indicators [Table Text Block]",
"terseLabel": "Amortized Cost Basis by Year of Origination and Credit Quality Indicator"
}
}
},
"localname": "FinancingReceivableCreditQualityIndicatorsTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
"auth_ref": [
"r193"
],
"calculation": {
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails": {
"order": 2.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
"label": "Finite-Lived Intangible Assets, Accumulated Amortization",
"negatedTerseLabel": "Accumulated Amortization"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
"auth_ref": [
"r195"
],
"calculation": {
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
"order": 2.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months",
"terseLabel": "2021"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
"order": 1.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year",
"terseLabel": "Remainder of 2020"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
"auth_ref": [
"r195"
],
"calculation": {
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
"order": 5.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four",
"terseLabel": "2024"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
"auth_ref": [
"r195"
],
"calculation": {
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
"order": 4.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three",
"terseLabel": "2023"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
"auth_ref": [
"r195"
],
"calculation": {
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
"order": 3.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two",
"terseLabel": "2022"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
"auth_ref": [
"r188",
"r191",
"r193",
"r196",
"r374"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by major type or class of finite-lived intangible assets.",
"label": "Finite-Lived Intangible Assets by Major Class [Axis]",
"terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
}
}
},
"localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails",
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsGross": {
"auth_ref": [
"r193",
"r374"
],
"calculation": {
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails": {
"order": 1.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
"label": "Finite-Lived Intangible Assets, Gross",
"terseLabel": "Gross Carrying Amount"
}
}
},
"localname": "FiniteLivedIntangibleAssetsGross",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Finite-Lived Intangible Assets [Line Items]",
"terseLabel": "Finite-Lived Intangible Assets [Line Items]"
}
}
},
"localname": "FiniteLivedIntangibleAssetsLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
"auth_ref": [
"r188",
"r192"
],
"lang": {
"en-US": {
"role": {
"documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
"label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
"terseLabel": "Patents and developed technology"
}
}
},
"localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails",
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsNet": {
"auth_ref": [
"r193"
],
"calculation": {
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
},
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
"label": "Finite-Lived Intangible Assets, Net",
"totalLabel": "Net Carrying Amount"
}
}
},
"localname": "FiniteLivedIntangibleAssetsNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails",
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FinitelivedIntangibleAssetsAcquired1": {
"auth_ref": [
"r189"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
"label": "Finite-lived Intangible Assets Acquired",
"terseLabel": "Finite-lived Intangible Assets Acquired"
}
}
},
"localname": "FinitelivedIntangibleAssetsAcquired1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ForeignCountryMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
"label": "Foreign Tax Authority [Member]",
"terseLabel": "Swiss"
}
}
},
"localname": "ForeignCountryMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
"auth_ref": [
"r351",
"r352",
"r353"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
"label": "Foreign Currency Transaction Gain (Loss), before Tax",
"terseLabel": "Foreign exchange gains/(losses) related to balance sheet re-measurement"
}
}
},
"localname": "ForeignCurrencyTransactionGainLossBeforeTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ForeignExchangeForwardMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
"label": "Foreign Exchange Forward [Member]",
"terseLabel": "Forward contracts"
}
}
},
"localname": "ForeignExchangeForwardMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ForeignGovernmentDebtSecuritiesMember": {
"auth_ref": [
"r238",
"r399"
],
"lang": {
"en-US": {
"role": {
"documentation": "Debt security issued by government not domiciled in United States of America (US).",
"label": "Debt Security, Government, Non-US [Member]",
"terseLabel": "Non-U.S. government securities"
}
}
},
"localname": "ForeignGovernmentDebtSecuritiesMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_GeographicDistributionAxis": {
"auth_ref": [
"r159"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.",
"label": "Geographic Distribution [Axis]",
"terseLabel": "Geographic Distribution [Axis]"
}
}
},
"localname": "GeographicDistributionAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_GeographicDistributionDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities.",
"label": "Geographic Distribution [Domain]",
"terseLabel": "Geographic Distribution [Domain]"
}
}
},
"localname": "GeographicDistributionDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_GeographicDistributionDomesticMember": {
"auth_ref": [
"r160"
],
"lang": {
"en-US": {
"role": {
"documentation": "Allocation of business activity identified as domestic.",
"label": "Geographic Distribution, Domestic [Member]",
"terseLabel": "U.S."
}
}
},
"localname": "GeographicDistributionDomesticMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_GeographicDistributionForeignMember": {
"auth_ref": [
"r161"
],
"lang": {
"en-US": {
"role": {
"documentation": "Allocation of business activity identified as foreign.",
"label": "Geographic Distribution, Foreign [Member]",
"terseLabel": "Outside of U.S. (\u201cOUS\u201d)"
}
}
},
"localname": "GeographicDistributionForeignMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_Goodwill": {
"auth_ref": [
"r180",
"r181"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 6.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
"label": "Goodwill",
"periodEndLabel": "Goodwill, Ending Balance",
"periodStartLabel": "Goodwill, Beginning Balance",
"terseLabel": "Goodwill"
}
}
},
"localname": "Goodwill",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails",
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GoodwillAcquiredDuringPeriod": {
"auth_ref": [
"r182"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
"label": "Goodwill, Acquired During Period",
"terseLabel": "Acquisition activity"
}
}
},
"localname": "GoodwillAcquiredDuringPeriod",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Goodwill and Intangible Assets Disclosure [Abstract]"
}
}
},
"localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
"auth_ref": [
"r197"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for goodwill and intangible assets.",
"label": "Goodwill and Intangible Assets Disclosure [Text Block]",
"terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
}
}
},
"localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_GoodwillRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
"label": "Goodwill [Roll Forward]",
"terseLabel": "Goodwill [Roll Forward]"
}
}
},
"localname": "GoodwillRollForward",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
"auth_ref": [
"r183",
"r184",
"r291"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
"label": "Goodwill, Translation and Purchase Accounting Adjustments",
"terseLabel": "Translation and other"
}
}
},
"localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GrossProfit": {
"auth_ref": [
"r76"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
"label": "Gross Profit",
"totalLabel": "Gross profit"
}
}
},
"localname": "GrossProfit",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_HedgingDesignationAxis": {
"auth_ref": [
"r325",
"r338"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by designation of purpose of derivative instrument.",
"label": "Hedging Designation [Axis]",
"terseLabel": "Hedging Designation"
}
}
},
"localname": "HedgingDesignationAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_HedgingDesignationDomain": {
"auth_ref": [
"r325"
],
"lang": {
"en-US": {
"role": {
"documentation": "Designation of purpose of derivative instrument.",
"label": "Hedging Designation [Domain]",
"terseLabel": "Hedging Designation [Domain]"
}
}
},
"localname": "HedgingDesignationDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
"auth_ref": [
"r103"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_ProfitLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
"label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
"totalLabel": "Income before taxes"
}
}
},
"localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeStatementAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Income Statement [Abstract]",
"terseLabel": "Income Statement [Abstract]"
}
}
},
"localname": "IncomeStatementAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_IncomeStatementLocationAxis": {
"auth_ref": [
"r201"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by location in the income statement.",
"label": "Income Statement Location [Axis]",
"terseLabel": "Income Statement Location"
}
}
},
"localname": "IncomeStatementLocationAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncomeStatementLocationDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Location in the income statement.",
"label": "Income Statement Location [Domain]",
"terseLabel": "Income Statement Location [Domain]"
}
}
},
"localname": "IncomeStatementLocationDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_IncomeTaxAuthorityAxis": {
"auth_ref": [
"r280"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by tax jurisdiction.",
"label": "Income Tax Authority [Axis]",
"terseLabel": "Income Tax Authority [Axis]"
}
}
},
"localname": "IncomeTaxAuthorityAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncomeTaxAuthorityDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
"label": "Income Tax Authority [Domain]",
"terseLabel": "Income Tax Authority [Domain]"
}
}
},
"localname": "IncomeTaxAuthorityDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_IncomeTaxContingencyLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Income Tax Contingency [Line Items]",
"terseLabel": "Income Tax Contingency [Line Items]"
}
}
},
"localname": "IncomeTaxContingencyLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncomeTaxContingencyTable": {
"auth_ref": [
"r281",
"r283",
"r284",
"r287"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
"label": "Income Tax Contingency [Table]",
"terseLabel": "Income Tax Contingency [Table]"
}
}
},
"localname": "IncomeTaxContingencyTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncomeTaxDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Income Tax Disclosure [Abstract]",
"terseLabel": "Income Tax Disclosure [Abstract]"
}
}
},
"localname": "IncomeTaxDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_IncomeTaxDisclosureTextBlock": {
"auth_ref": [
"r290"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
"label": "Income Tax Disclosure [Text Block]",
"terseLabel": "INCOME TAXES"
}
}
},
"localname": "IncomeTaxDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/INCOMETAXES"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_IncomeTaxExpenseBenefit": {
"auth_ref": [
"r100",
"r122",
"r289"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_ProfitLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
"label": "Income Tax Expense (Benefit)",
"terseLabel": "Income tax expense",
"verboseLabel": "Income tax expense (benefit)"
}
}
},
"localname": "IncomeTaxExpenseBenefit",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
"http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
"auth_ref": [
"r277",
"r278",
"r279"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
"label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
"terseLabel": "Re-measurement of deferred tax assets"
}
}
},
"localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInAccountsPayable": {
"auth_ref": [
"r93"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 11.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
"label": "Increase (Decrease) in Accounts Payable",
"terseLabel": "Accounts payable"
}
}
},
"localname": "IncreaseDecreaseInAccountsPayable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInAccountsReceivable": {
"auth_ref": [
"r93"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 8.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
"label": "Increase (Decrease) in Accounts Receivable",
"negatedLabel": "Accounts receivable"
}
}
},
"localname": "IncreaseDecreaseInAccountsReceivable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInDeferredRevenue": {
"auth_ref": [
"r93"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 13.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
"label": "Increase (Decrease) in Deferred Revenue",
"terseLabel": "Deferred revenue"
}
}
},
"localname": "IncreaseDecreaseInDeferredRevenue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
"auth_ref": [
"r93"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 12.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
"label": "Increase (Decrease) in Employee Related Liabilities",
"terseLabel": "Accrued compensation and employee benefits"
}
}
},
"localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInInventories": {
"auth_ref": [
"r93"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 9.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
"label": "Increase (Decrease) in Inventories",
"negatedLabel": "Inventory"
}
}
},
"localname": "IncreaseDecreaseInInventories",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Increase (Decrease) in Operating Capital [Abstract]",
"terseLabel": "Changes in operating assets and liabilities, net of effects of acquisition:"
}
}
},
"localname": "IncreaseDecreaseInOperatingCapitalAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
"auth_ref": [
"r93"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 14.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
"label": "Increase (Decrease) in Other Operating Liabilities",
"terseLabel": "Other liabilities"
}
}
},
"localname": "IncreaseDecreaseInOtherOperatingLiabilities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
"auth_ref": [
"r93"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 10.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
"label": "Increase (Decrease) in Prepaid Expense and Other Assets",
"negatedLabel": "Prepaids and other assets"
}
}
},
"localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
"label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
"terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
}
}
},
"localname": "IncreaseDecreaseInStockholdersEquityRollForward",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_InternalCreditAssessmentAxis": {
"auth_ref": [
"r128",
"r157",
"r162",
"r163",
"r206",
"r340"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by entity-defined rating.",
"label": "Internal Credit Assessment [Axis]",
"terseLabel": "Internal Credit Assessment [Axis]"
}
}
},
"localname": "InternalCreditAssessmentAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_InternalCreditAssessmentDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Entity defined credit risk rating.",
"label": "Internal Credit Assessment [Domain]",
"terseLabel": "Internal Credit Assessment [Domain]"
}
}
},
"localname": "InternalCreditAssessmentDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_InventoryFinishedGoodsNetOfReserves": {
"auth_ref": [
"r27",
"r175"
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails": {
"order": 3.0,
"parentTag": "us-gaap_InventoryNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
"label": "Inventory, Finished Goods, Net of Reserves",
"terseLabel": "Finished goods"
}
}
},
"localname": "InventoryFinishedGoodsNetOfReserves",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InventoryNet": {
"auth_ref": [
"r1",
"r50",
"r174"
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
},
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
"label": "Inventory, Net",
"terseLabel": "Inventory",
"totalLabel": "Total inventory"
}
}
},
"localname": "InventoryNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails",
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InventoryRawMaterialsNetOfReserves": {
"auth_ref": [
"r29",
"r175"
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails": {
"order": 1.0,
"parentTag": "us-gaap_InventoryNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
"label": "Inventory, Raw Materials, Net of Reserves",
"terseLabel": "Raw materials"
}
}
},
"localname": "InventoryRawMaterialsNetOfReserves",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InventoryWorkInProcessNetOfReserves": {
"auth_ref": [
"r28",
"r175"
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails": {
"order": 2.0,
"parentTag": "us-gaap_InventoryNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
"label": "Inventory, Work in Process, Net of Reserves",
"terseLabel": "Work-in-process"
}
}
},
"localname": "InventoryWorkInProcessNetOfReserves",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Investments, All Other Investments [Abstract]",
"terseLabel": "Investments, All Other Investments [Abstract]"
}
}
},
"localname": "InvestmentsAllOtherInvestmentsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
"label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
"terseLabel": "Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments"
}
}
},
"localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_LeasesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Leases [Abstract]",
"terseLabel": "Leases [Abstract]"
}
}
},
"localname": "LeasesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_LessorLeaseDescriptionLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Lessor, Lease, Description [Line Items]",
"terseLabel": "Lessor, Lease, Description [Line Items]"
}
}
},
"localname": "LessorLeaseDescriptionLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_LessorLeaseDescriptionTable": {
"auth_ref": [
"r366"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about lessor's leases.",
"label": "Lessor, Lease, Description [Table]",
"terseLabel": "Lessor, Lease, Description [Table]"
}
}
},
"localname": "LessorLeaseDescriptionTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_LessorSalesTypeLeaseTermOfContract1": {
"auth_ref": [
"r365"
],
"lang": {
"en-US": {
"role": {
"documentation": "Term of lessor's sales-type lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
"label": "Lessor, Sales-type Lease, Term of Contract",
"terseLabel": "Sales-type leases terms"
}
}
},
"localname": "LessorSalesTypeLeaseTermOfContract1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
],
"xbrltype": "durationItemType"
},
"us-gaap_LessorSalesTypeLeasesTextBlock": {
"auth_ref": [
"r369"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure of lessor's sales-type leases.",
"label": "Lessor, Sales-type Leases [Text Block]",
"terseLabel": "LEASES"
}
}
},
"localname": "LessorSalesTypeLeasesTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASES"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_Liabilities": {
"auth_ref": [
"r40"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
"label": "Liabilities",
"totalLabel": "Total liabilities"
}
}
},
"localname": "Liabilities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquity": {
"auth_ref": [
"r25",
"r378",
"r391"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
"label": "Liabilities and Equity",
"totalLabel": "Total liabilities and stockholders\u2019 equity"
}
}
},
"localname": "LiabilitiesAndStockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Liabilities and Equity [Abstract]",
"terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
}
}
},
"localname": "LiabilitiesAndStockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_LiabilitiesCurrent": {
"auth_ref": [
"r43"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
"label": "Liabilities, Current",
"totalLabel": "Total current liabilities"
}
}
},
"localname": "LiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Liabilities, Current [Abstract]",
"terseLabel": "Current liabilities:"
}
}
},
"localname": "LiabilitiesCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
},
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.",
"label": "Liabilities, Other than Long-term Debt, Noncurrent",
"terseLabel": "Other long-term liabilities",
"totalLabel": "Total other long-term liabilities"
}
}
},
"localname": "LiabilitiesOtherThanLongtermDebtNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails",
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LitigationReserveCurrent": {
"auth_ref": [
"r45",
"r203",
"r204"
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails": {
"order": 2.0,
"parentTag": "us-gaap_OtherLiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
"label": "Estimated Litigation Liability, Current",
"terseLabel": "Litigation related accruals"
}
}
},
"localname": "LitigationReserveCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_MarketableSecuritiesCurrent": {
"auth_ref": [
"r3",
"r41"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of investment in marketable security, classified as current.",
"label": "Marketable Securities, Current",
"terseLabel": "Short- term Investments",
"verboseLabel": "Short-term investments"
}
}
},
"localname": "MarketableSecuritiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_MarketableSecuritiesNoncurrent": {
"auth_ref": [
"r36"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of investment in marketable security, classified as noncurrent.",
"label": "Marketable Securities, Noncurrent",
"terseLabel": "Long- term Investments",
"verboseLabel": "Long-term investments"
}
}
},
"localname": "MarketableSecuritiesNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_MinorityInterest": {
"auth_ref": [
"r49",
"r377",
"r390"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
"label": "Stockholders' Equity Attributable to Noncontrolling Interest",
"terseLabel": "Noncontrolling interest in joint venture"
}
}
},
"localname": "MinorityInterest",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_MoneyMarketFundsMember": {
"auth_ref": [
"r238"
],
"lang": {
"en-US": {
"role": {
"documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
"label": "Money Market Funds [Member]",
"terseLabel": "Money market funds"
}
}
},
"localname": "MoneyMarketFundsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_MunicipalNotesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Short-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.",
"label": "Municipal Notes [Member]",
"terseLabel": "Municipal securities"
}
}
},
"localname": "MunicipalNotesMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_NatureOfOperations": {
"auth_ref": [
"r120",
"r121"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
"label": "Nature of Operations [Text Block]",
"terseLabel": "DESCRIPTION OF THE BUSINESS"
}
}
},
"localname": "NatureOfOperations",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivities": {
"auth_ref": [
"r91"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
"label": "Net Cash Provided by (Used in) Financing Activities",
"totalLabel": "Net cash provided by (used in) financing activities"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
"terseLabel": "Financing activities:"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInInvestingActivities": {
"auth_ref": [
"r91"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
"label": "Net Cash Provided by (Used in) Investing Activities",
"totalLabel": "Net cash provided by (used in) investing activities"
}
}
},
"localname": "NetCashProvidedByUsedInInvestingActivities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
"terseLabel": "Investing activities:"
}
}
},
"localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivities": {
"auth_ref": [
"r91",
"r92",
"r95"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
"label": "Net Cash Provided by (Used in) Operating Activities",
"totalLabel": "Net cash provided by operating activities"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
"terseLabel": "Operating activities:"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetIncomeLoss": {
"auth_ref": [
"r67",
"r70",
"r74",
"r95",
"r116",
"r381",
"r394"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
"label": "Net Income (Loss) Attributable to Parent",
"terseLabel": "Net income attributable to Intuitive Surgical, Inc.",
"totalLabel": "Net income attributable to Intuitive Surgical, Inc."
}
}
},
"localname": "NetIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
"http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
"auth_ref": [
"r67",
"r70",
"r311",
"r316"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
"label": "Net Income (Loss) Attributable to Noncontrolling Interest",
"terseLabel": "Less: net loss attributable to noncontrolling interest in joint venture",
"verboseLabel": "Net income attributable to noncontrolling interest in joint venture"
}
}
},
"localname": "NetIncomeLossAttributableToNoncontrollingInterest",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
"terseLabel": "Numerator:"
}
}
},
"localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
"label": "New Accounting Pronouncements, Policy [Policy Text Block]",
"terseLabel": "Recent Accounting Pronouncements"
}
}
},
"localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_NoncompeteAgreementsMember": {
"auth_ref": [
"r297"
],
"lang": {
"en-US": {
"role": {
"documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
"label": "Noncompete Agreements [Member]",
"terseLabel": "Non-compete provisions"
}
}
},
"localname": "NoncompeteAgreementsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_NoncontrollingInterestMember": {
"auth_ref": [
"r305"
],
"lang": {
"en-US": {
"role": {
"documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
"label": "Noncontrolling Interest [Member]",
"terseLabel": "Noncontrolling Interest in Joint Venture"
}
}
},
"localname": "NoncontrollingInterestMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_NondesignatedMember": {
"auth_ref": [
"r325"
],
"lang": {
"en-US": {
"role": {
"documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
"label": "Not Designated as Hedging Instrument [Member]",
"terseLabel": "Derivatives Not Designated as Hedging Instruments"
}
}
},
"localname": "NondesignatedMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_NonoperatingIncomeExpense": {
"auth_ref": [
"r79"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
"label": "Nonoperating Income (Expense)",
"terseLabel": "Interest and other income, net"
}
}
},
"localname": "NonoperatingIncomeExpense",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingExpenses": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
"label": "Operating Expenses",
"totalLabel": "Total operating expenses"
}
}
},
"localname": "OperatingExpenses",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingExpensesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Operating Expenses [Abstract]",
"terseLabel": "Operating expenses:"
}
}
},
"localname": "OperatingExpensesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_OperatingIncomeLoss": {
"auth_ref": [
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The net result for the period of deducting operating expenses from operating revenues.",
"label": "Operating Income (Loss)",
"totalLabel": "Income from operations"
}
}
},
"localname": "OperatingIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeaseLeaseIncome": {
"auth_ref": [
"r119",
"r363",
"r367"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.",
"label": "Operating Lease, Lease Income",
"terseLabel": "Operating lease revenue"
}
}
},
"localname": "OperatingLeaseLeaseIncome",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": {
"auth_ref": [
"r119",
"r367"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of components of income from operating lease.",
"label": "Operating Lease, Lease Income [Table Text Block]",
"terseLabel": "Operating Lease Revenue"
}
}
},
"localname": "OperatingLeaseLeaseIncomeTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
"terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
}
}
},
"localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_OtherAccruedLiabilitiesCurrent": {
"auth_ref": [
"r10",
"r11",
"r12",
"r42"
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails": {
"order": 3.0,
"parentTag": "us-gaap_OtherLiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
"label": "Other Accrued Liabilities, Current",
"terseLabel": "Other accrued liabilities"
}
}
},
"localname": "OtherAccruedLiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherAccruedLiabilitiesNoncurrent": {
"auth_ref": [
"r44"
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails": {
"order": 3.0,
"parentTag": "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
"label": "Other Accrued Liabilities, Noncurrent",
"terseLabel": "Other long-term liabilities"
}
}
},
"localname": "OtherAccruedLiabilitiesNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
"auth_ref": [
"r58",
"r60",
"r307",
"r313"
],
"calculation": {
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
"label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
"totalLabel": "Net current-period other comprehensive income (loss)"
}
}
},
"localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent [Abstract]",
"terseLabel": "Employee Benefit Plans"
}
}
},
"localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
"auth_ref": [
"r54",
"r60",
"r355",
"r356",
"r359",
"r360"
],
"calculation": {
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
"order": 1.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
"label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
"terseLabel": "Other comprehensive income (loss) before reclassifications"
}
}
},
"localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
"auth_ref": [
"r56",
"r57"
],
"calculation": {
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
"order": 1.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities and unrealized holding gain (loss) related to transfers of securities into the available-for-sale classification and out of the held-to-maturity classification.",
"label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Reclassification Adjustments, after Tax",
"terseLabel": "Other comprehensive income (loss) before reclassifications"
}
}
},
"localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
"auth_ref": [
"r56",
"r57",
"r60"
],
"calculation": {
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.",
"label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax",
"totalLabel": "Net current-period other comprehensive income (loss)"
}
}
},
"localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": {
"auth_ref": [
"r55"
],
"calculation": {
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
"label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax",
"totalLabel": "Net current-period other comprehensive income (loss)"
}
}
},
"localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
"auth_ref": [
"r53",
"r357"
],
"calculation": {
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
"label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
"totalLabel": "Net current-period other comprehensive income (loss)"
}
}
},
"localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": {
"auth_ref": [
"r60",
"r63",
"r64",
"r65",
"r358"
],
"calculation": {
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
"order": 2.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
"label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax",
"negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
}
}
},
"localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
"auth_ref": [
"r68",
"r71",
"r73",
"r211"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
"label": "Other Comprehensive Income (Loss), Net of Tax",
"terseLabel": "Other comprehensive income (loss)"
}
}
},
"localname": "OtherComprehensiveIncomeLossNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
"auth_ref": [
"r68",
"r71",
"r307",
"r308",
"r313"
],
"calculation": {
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
"label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
"totalLabel": "Net current-period other comprehensive income (loss)"
}
}
},
"localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
"auth_ref": [
"r58",
"r60"
],
"calculation": {
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
"order": 1.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
"label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax",
"terseLabel": "Other comprehensive income (loss) before reclassifications"
}
}
},
"localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
"auth_ref": [
"r60",
"r63",
"r65",
"r146"
],
"calculation": {
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
"order": 2.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
"label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
"negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
}
}
},
"localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax": {
"auth_ref": [
"r60",
"r63",
"r65",
"r326"
],
"calculation": {
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
"order": 2.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).",
"label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax",
"negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
}
}
},
"localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax": {
"auth_ref": [
"r60",
"r63",
"r65",
"r240"
],
"calculation": {
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
"order": 2.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.",
"label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax",
"negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
}
}
},
"localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax": {
"auth_ref": [
"r55",
"r60",
"r344"
],
"calculation": {
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
"order": 1.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
"label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax",
"terseLabel": "Other comprehensive income (loss) before reclassifications"
}
}
},
"localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of other current liabilities.",
"label": "Other Current Liabilities [Table Text Block]",
"terseLabel": "Other Accrued Liabilities - Short-term"
}
}
},
"localname": "OtherCurrentLiabilitiesTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_OtherIncomeMember": {
"auth_ref": [
"r339"
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing other revenue.",
"label": "Other Income [Member]",
"terseLabel": "Other income"
}
}
},
"localname": "OtherIncomeMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_OtherLiabilitiesCurrent": {
"auth_ref": [
"r9",
"r10",
"r42"
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
},
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
"label": "Other Liabilities, Current",
"terseLabel": "Other accrued liabilities",
"totalLabel": "Total other accrued liabilities\u2014short-term"
}
}
},
"localname": "OtherLiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails",
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherLiabilitiesMember": {
"auth_ref": [
"r328",
"r343"
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing other liabilities.",
"label": "Other Liabilities [Member]",
"terseLabel": "Other accrued liabilities"
}
}
},
"localname": "OtherLiabilitiesMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Other Noncash Investing and Financing Items [Abstract]",
"terseLabel": "Supplemental non-cash investing activities:"
}
}
},
"localname": "OtherNoncashInvestingAndFinancingItemsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_OtherNoncurrentAssetsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing other noncurrent assets.",
"label": "Other Noncurrent Assets [Member]",
"terseLabel": "Intangible and other assets, net"
}
}
},
"localname": "OtherNoncurrentAssetsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of other noncurrent liabilities.",
"label": "Other Noncurrent Liabilities [Table Text Block]",
"terseLabel": "Other Long-term Liabilities"
}
}
},
"localname": "OtherNoncurrentLiabilitiesTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_OtherPrepaidExpenseCurrent": {
"auth_ref": [
"r4",
"r7"
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails": {
"order": 4.0,
"parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
"label": "Other Prepaid Expense, Current",
"terseLabel": "Other prepaids and other current assets"
}
}
},
"localname": "OtherPrepaidExpenseCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ParentMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
"label": "Parent [Member]",
"terseLabel": "Total Intuitive Surgical, Inc. Stockholders\u2019 Equity"
}
}
},
"localname": "ParentMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
"auth_ref": [
"r88"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
"label": "Payment for Contingent Consideration Liability, Financing Activities",
"terseLabel": "Payment of contingent liability"
}
}
},
"localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsForRepurchaseOfCommonStock": {
"auth_ref": [
"r87"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow to reacquire common stock during the period.",
"label": "Payments for Repurchase of Common Stock",
"negatedLabel": "Repurchase of common stock",
"terseLabel": "Repurchase of common stock"
}
}
},
"localname": "PaymentsForRepurchaseOfCommonStock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
"auth_ref": [
"r87"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
"label": "Payment, Tax Withholding, Share-based Payment Arrangement",
"negatedTerseLabel": "Taxes paid related to net share settlement of equity awards"
}
}
},
"localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquireBusinessesGross": {
"auth_ref": [
"r83",
"r304"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
"label": "Payments to Acquire Businesses, Gross",
"terseLabel": "Cash payments"
}
}
},
"localname": "PaymentsToAcquireBusinessesGross",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
"auth_ref": [
"r83"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 5.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
"label": "Payments to Acquire Businesses, Net of Cash Acquired",
"negatedLabel": "Acquisition of businesses, net of cash"
}
}
},
"localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquireMarketableSecurities": {
"auth_ref": [
"r131"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash outflow for purchase of marketable security.",
"label": "Payments to Acquire Marketable Securities",
"negatedLabel": "Purchase of investments"
}
}
},
"localname": "PaymentsToAcquireMarketableSecurities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquireProductiveAssets": {
"auth_ref": [
"r84"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
"label": "Payments to Acquire Productive Assets",
"negatedLabel": "Purchase of property, plant, and equipment and intellectual property"
}
}
},
"localname": "PaymentsToAcquireProductiveAssets",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PlanNameAxis": {
"auth_ref": [
"r246",
"r268"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by plan name for share-based payment arrangement.",
"label": "Plan Name [Axis]",
"terseLabel": "Plan Name [Axis]"
}
}
},
"localname": "PlanNameAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_PlanNameDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Plan name for share-based payment arrangement.",
"label": "Plan Name [Domain]",
"terseLabel": "Plan Name [Domain]"
}
}
},
"localname": "PlanNameDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_PreferredStockParOrStatedValuePerShare": {
"auth_ref": [
"r18"
],
"lang": {
"en-US": {
"role": {
"documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
"label": "Preferred Stock, Par or Stated Value Per Share",
"terseLabel": "Preferred stock, par value (in dollars per share)"
}
}
},
"localname": "PreferredStockParOrStatedValuePerShare",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "perShareItemType"
},
"us-gaap_PreferredStockSharesAuthorized": {
"auth_ref": [
"r18"
],
"lang": {
"en-US": {
"role": {
"documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
"label": "Preferred Stock, Shares Authorized",
"terseLabel": "Preferred stock, shares authorized (in shares)"
}
}
},
"localname": "PreferredStockSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockSharesIssued": {
"auth_ref": [
"r18"
],
"lang": {
"en-US": {
"role": {
"documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
"label": "Preferred Stock, Shares Issued",
"terseLabel": "Preferred stock, shares issued (in shares)"
}
}
},
"localname": "PreferredStockSharesIssued",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockSharesOutstanding": {
"auth_ref": [
"r18"
],
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
"label": "Preferred Stock, Shares Outstanding",
"terseLabel": "Preferred stock, shares outstanding (in shares)"
}
}
},
"localname": "PreferredStockSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockValue": {
"auth_ref": [
"r18"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
"label": "Preferred Stock, Value, Issued",
"terseLabel": "Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of June 30, 2020, and December 31, 2019"
}
}
},
"localname": "PreferredStockValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
"auth_ref": [
"r6",
"r33",
"r34"
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
},
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 5.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
"label": "Prepaid Expense and Other Assets, Current",
"terseLabel": "Prepaids and other current assets",
"totalLabel": "Prepaids and other current assets"
}
}
},
"localname": "PrepaidExpenseAndOtherAssetsCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails",
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
"label": "Prepaid Expenses and Other Current Assets [Member]",
"terseLabel": "Prepaids and other current assets"
}
}
},
"localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails",
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails",
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_PrepaidTaxes": {
"auth_ref": [
"r5",
"r7",
"r176",
"r177"
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails": {
"order": 2.0,
"parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
"label": "Prepaid Taxes",
"terseLabel": "Prepaid taxes"
}
}
},
"localname": "PrepaidTaxes",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
"auth_ref": [
"r80",
"r81",
"r131"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
"label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale",
"terseLabel": "Proceeds from maturities of investments"
}
}
},
"localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromMinorityShareholders": {
"auth_ref": [
"r86"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
"label": "Proceeds from Noncontrolling Interests",
"terseLabel": "Capital contribution from noncontrolling interest"
}
}
},
"localname": "ProceedsFromMinorityShareholders",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
"auth_ref": [
"r86",
"r89",
"r106"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
"label": "Proceeds from (Payments for) Other Financing Activities",
"terseLabel": "Payment of deferred purchase consideration"
}
}
},
"localname": "ProceedsFromPaymentsForOtherFinancingActivities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities": {
"auth_ref": [
"r82",
"r131"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.",
"label": "Proceeds from Sale of Available-for-sale Securities",
"terseLabel": "Proceeds from Sale of Investments"
}
}
},
"localname": "ProceedsFromSaleOfAvailableForSaleSecurities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromStockPlans": {
"auth_ref": [
"r85"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 5.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
"label": "Proceeds from Stock Plans",
"terseLabel": "Proceeds from issuance of common stock relating to employee stock plans"
}
}
},
"localname": "ProceedsFromStockPlans",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProductMember": {
"auth_ref": [
"r236"
],
"lang": {
"en-US": {
"role": {
"documentation": "Article or substance produced by nature, labor or machinery.",
"label": "Product [Member]",
"terseLabel": "Product"
}
}
},
"localname": "ProductMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_ProfitLoss": {
"auth_ref": [
"r67",
"r70",
"r90",
"r123",
"r124",
"r307",
"r310",
"r312",
"r316",
"r317"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
},
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
"label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
"terseLabel": "Net income",
"totalLabel": "Net income"
}
}
},
"localname": "ProfitLoss",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PropertyPlantAndEquipmentNet": {
"auth_ref": [
"r15",
"r16",
"r199",
"r392"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
"label": "Property, Plant and Equipment, Net",
"terseLabel": "Property, plant, and equipment, net"
}
}
},
"localname": "PropertyPlantAndEquipmentNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PropertyPlantAndEquipmentTransfersAndChanges": {
"auth_ref": [
"r200"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) of physical assets used in the normal conduct of business and not intended for resale, from reclassification, impairment, donation, or changes classified as other. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
"label": "Property, Plant and Equipment, Transfers and Changes",
"terseLabel": "Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment"
}
}
},
"localname": "PropertyPlantAndEquipmentTransfersAndChanges",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RealizedInvestmentGainsLosses": {
"auth_ref": [
"r396"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The net realized gains or losses on investments during the period, not including gains or losses on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity.",
"label": "Realized Investment Gains (Losses)",
"terseLabel": "Realized Investment Gains (Losses)"
}
}
},
"localname": "RealizedInvestmentGainsLosses",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
"auth_ref": [
"r62",
"r66",
"r73"
],
"calculation": {
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
"order": 2.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
"label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
"negatedLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
}
}
},
"localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ResearchAndDevelopmentExpense": {
"auth_ref": [
"r274",
"r400"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
"label": "Research and Development Expense",
"terseLabel": "Research and development"
}
}
},
"localname": "ResearchAndDevelopmentExpense",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RestrictedStockUnitsRSUMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
"label": "Restricted Stock Units (RSUs) [Member]",
"terseLabel": "Restricted Stock Units (RSUs)"
}
}
},
"localname": "RestrictedStockUnitsRSUMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_RetainedEarningsAccumulatedDeficit": {
"auth_ref": [
"r22",
"r218",
"r389"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Retained Earnings (Accumulated Deficit)",
"terseLabel": "Retained earnings"
}
}
},
"localname": "RetainedEarningsAccumulatedDeficit",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RetainedEarningsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Retained Earnings [Member]",
"terseLabel": "Retained Earnings"
}
}
},
"localname": "RetainedEarningsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_RevenueFromContractWithCustomerAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Revenue from Contract with Customer [Abstract]",
"terseLabel": "Revenue from Contract with Customer [Abstract]"
}
}
},
"localname": "RevenueFromContractWithCustomerAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
"auth_ref": [
"r232",
"r233"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_GrossProfit",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
"label": "Revenue from Contract with Customer, Excluding Assessed Tax",
"terseLabel": "Total revenue"
}
}
},
"localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RevenueFromContractWithCustomerTextBlock": {
"auth_ref": [
"r237"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
"label": "Revenue from Contract with Customer [Text Block]",
"terseLabel": "REVENUE AND CONTRACT ACQUISITION COSTS"
}
}
},
"localname": "RevenueFromContractWithCustomerTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_RevenueRemainingPerformanceObligation": {
"auth_ref": [
"r229"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
"label": "Revenue, Remaining Performance Obligation, Amount",
"terseLabel": "Price allocated to remaining performance obligations"
}
}
},
"localname": "RevenueRemainingPerformanceObligation",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation": {
"auth_ref": [
"r231"
],
"lang": {
"en-US": {
"role": {
"documentation": "Description of when remaining performance obligation is expected to be recognized as revenue.",
"label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Explanation",
"terseLabel": "Timing of performance obligation"
}
}
},
"localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
"terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
}
}
},
"localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
"auth_ref": [
"r230"
],
"lang": {
"en-US": {
"role": {
"documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
"label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
"terseLabel": "Remaining performance obligations"
}
}
},
"localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
],
"xbrltype": "durationItemType"
},
"us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
"auth_ref": [
"r230"
],
"lang": {
"en-US": {
"role": {
"documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.",
"label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
"terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
}
}
},
"localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
"label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
"terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
}
}
},
"localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_RevenuesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Revenues [Abstract]",
"terseLabel": "Revenue:"
}
}
},
"localname": "RevenuesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock": {
"auth_ref": [
"r364"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received on annual basis for sales-type and direct financing leases receivable. Includes, but is not limited to, reconciliation to lease receivable recognized in statement of financial position.",
"label": "Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block]",
"terseLabel": "Schedule of Contractual Maturities of Gross Lease Receivables"
}
}
},
"localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived": {
"auth_ref": [
"r364"
],
"calculation": {
"http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.",
"label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received",
"totalLabel": "Total"
}
}
},
"localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears": {
"auth_ref": [
"r364"
],
"calculation": {
"http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
"order": 5.0,
"parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in fourth fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Four Years",
"terseLabel": "2024"
}
}
},
"localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths": {
"auth_ref": [
"r364"
],
"calculation": {
"http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
"order": 2.0,
"parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in the next fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on rolling approach, from latest statement of financial position date.",
"label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Next Twelve Months",
"terseLabel": "2021"
}
}
},
"localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear": {
"auth_ref": [
"r364"
],
"calculation": {
"http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
"order": 1.0,
"parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in remainder of the fiscal year following latest fiscal year. Excludes interim and annual period when interim periods are reported on a rolling approach, from latest statement of financial position date.",
"label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Remainder of Fiscal Year",
"terseLabel": "Remainder of 2020"
}
}
},
"localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears": {
"auth_ref": [
"r364"
],
"calculation": {
"http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
"order": 4.0,
"parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in third fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
"label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Three Years",
"terseLabel": "2023"
}
}
},
"localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears": {
"auth_ref": [
"r364"
],
"calculation": {
"http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
"order": 3.0,
"parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in second fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
"label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Two Years",
"terseLabel": "2022"
}
}
},
"localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeLeaseLeaseIncome": {
"auth_ref": [
"r119",
"r363",
"r367"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of lease income from variable lease payments, interest income from net investment on sales-type lease, and profit (loss) recognized at commencement.",
"label": "Sales-type Lease, Lease Income",
"terseLabel": "Sales-type lease revenue"
}
}
},
"localname": "SalesTypeLeaseLeaseIncome",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock": {
"auth_ref": [
"r119",
"r367"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of components of income from sales-type lease.",
"label": "Sales-type Lease, Lease Income [Table Text Block]",
"terseLabel": "Sales-type Lease Revenue"
}
}
},
"localname": "SalesTypeLeaseLeaseIncomeTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SalesTypeLeaseLeaseReceivable": {
"auth_ref": [
"r368"
],
"calculation": {
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails": {
"order": 1.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type lease.",
"label": "Sales-type Lease, Lease Receivable",
"terseLabel": "Gross lease receivables"
}
}
},
"localname": "SalesTypeLeaseLeaseReceivable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeLeaseNetInvestmentInLease": {
"auth_ref": [
"r368"
],
"calculation": {
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
},
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
},
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of net investment in sales-type lease.",
"label": "Sales-type Lease, Net Investment in Lease",
"totalLabel": "Net investment in sales-type leases"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLease",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails",
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss": {
"auth_ref": [
"r149",
"r151",
"r153"
],
"calculation": {
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails": {
"order": 2.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of allowance for credit loss on net investment in sales-type lease.",
"label": "Sales-type Lease, Net Investment in Lease, Allowance for Credit Loss",
"negatedTerseLabel": "Allowance for credit loss"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLossWriteoff": {
"auth_ref": [
"r152"
],
"calculation": {
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of writeoff of net investment in sales-type lease, charged against allowance for credit loss.",
"label": "Sales-type Lease, Net Investment in Lease, Allowance for Credit Loss, Writeoff",
"totalLabel": "Current-period net write-offs"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLossWriteoff",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]",
"terseLabel": "Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable": {
"auth_ref": [
"r157"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about credit quality indicator for net investment in sales-type lease.",
"label": "Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Table]",
"terseLabel": "Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Table]"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear": {
"auth_ref": [
"r158"
],
"calculation": {
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails": {
"order": 5.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of net investment in sales-type lease originated five or more years prior to latest fiscal year.",
"label": "Sales-type Lease, Net Investment in Lease, Originated Five or More Years before Latest Fiscal Year",
"terseLabel": "Prior"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear": {
"auth_ref": [
"r158"
],
"calculation": {
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails": {
"order": 6.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of net investment in sales-type lease originated four years prior to latest fiscal year.",
"label": "Sales-type Lease, Net Investment in Lease, Originated Four Years before Latest Fiscal Year",
"terseLabel": "2016"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear": {
"auth_ref": [
"r158"
],
"calculation": {
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails": {
"order": 3.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of net investment in sales-type lease originated in current fiscal year.",
"label": "Sales-type Lease, Net Investment in Lease, Originated in Current Fiscal Year",
"terseLabel": "2020"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear": {
"auth_ref": [
"r158"
],
"calculation": {
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails": {
"order": 2.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of net investment in sales-type lease originated in fiscal year prior to latest fiscal year.",
"label": "Sales-type Lease, Net Investment in Lease, Originated in Fiscal Year before Latest Fiscal Year",
"terseLabel": "2019"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear": {
"auth_ref": [
"r158"
],
"calculation": {
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails": {
"order": 4.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of net investment in sales-type lease originated three years prior to latest fiscal year.",
"label": "Sales-type Lease, Net Investment in Lease, Originated Three Years before Latest Fiscal Year",
"terseLabel": "2017"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear": {
"auth_ref": [
"r158"
],
"calculation": {
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails": {
"order": 1.0,
"parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of net investment in sales-type lease originated two years prior to latest fiscal year.",
"label": "Sales-type Lease, Net Investment in Lease, Originated Two Years before Latest Fiscal Year",
"terseLabel": "2018"
}
}
},
"localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAmortizedCostBasisbyYearofOriginationandCreditQualityIndicatorDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
"auth_ref": [
"r62"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
"label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
"terseLabel": "Components of Accumulated Other Comprehensive Income, Net of Tax"
}
}
},
"localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Debt Securities, Available-for-sale [Line Items]",
"terseLabel": "Debt Securities, Available-for-sale [Line Items]"
}
}
},
"localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
"auth_ref": [
"r138",
"r141",
"r142",
"r143",
"r144",
"r145",
"r383",
"r386"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
"label": "Schedule of Available-for-sale Securities [Table]",
"terseLabel": "Schedule of Available-for-sale Securities [Table]"
}
}
},
"localname": "ScheduleOfAvailableForSaleSecuritiesTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
"auth_ref": [
"r292",
"r293"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
"label": "Schedule of Business Acquisitions, by Acquisition [Table]",
"terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
}
}
},
"localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfCapitalLeasedAsssetsTable": {
"auth_ref": [
"r361"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule of long-lived, depreciable assets that are subject to a lease meeting the criteria for capitalization and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
"label": "Schedule of Capital Leased Assets [Table]",
"terseLabel": "Schedule of Capital Leased Assets [Table]"
}
}
},
"localname": "ScheduleOfCapitalLeasedAsssetsTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
"label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
"terseLabel": "Supplemental Cash Flow Information"
}
}
},
"localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
"auth_ref": [
"r266"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
"label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
"terseLabel": "Summary of Share-Based Compensation Expense"
}
}
},
"localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
"auth_ref": [
"r105",
"r321",
"r323",
"r324",
"r325",
"r327",
"r333",
"r335",
"r341",
"r342"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
"label": "Schedule of Derivative Instruments [Table Text Block]",
"terseLabel": "Gross Notional Amounts for Derivatives and Aggregate Gross Fair Value Outstanding"
}
}
},
"localname": "ScheduleOfDerivativeInstrumentsTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
"auth_ref": [
"r116"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
"label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
"terseLabel": "Computation of Basic and Diluted Net Income Per Share"
}
}
},
"localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
"auth_ref": [
"r244",
"r266",
"r270"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
"label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
"terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
}
}
},
"localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
"auth_ref": [
"r188",
"r192"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
"label": "Schedule of Finite-Lived Intangible Assets [Table]",
"terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
}
}
},
"localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
"auth_ref": [
"r188",
"r192"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
"label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
"terseLabel": "Schedule of Intangible Assets"
}
}
},
"localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfGoodwillTextBlock": {
"auth_ref": [
"r185",
"r186"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
"label": "Schedule of Goodwill [Table Text Block]",
"terseLabel": "Schedule of Summary of Changes in Goodwill"
}
}
},
"localname": "ScheduleOfGoodwillTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
"auth_ref": [
"r13",
"r30",
"r31",
"r32"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
"label": "Schedule of Inventory, Current [Table Text Block]",
"terseLabel": "Inventory Details"
}
}
},
"localname": "ScheduleOfInventoryCurrentTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
"auth_ref": [
"r334",
"r336"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
"label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
"terseLabel": "Derivatives Not Designated as Hedging Instruments"
}
}
},
"localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
"auth_ref": [
"r246",
"r268"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about share-based payment arrangement.",
"label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
"terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
}
}
},
"localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails",
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
"auth_ref": [
"r248"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
"label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
"terseLabel": "Summary of RSU Activity"
}
}
},
"localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
"auth_ref": [
"r248",
"r260",
"r262"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
"label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
"terseLabel": "Summary of Stock Option Activity Under All Stock Plans"
}
}
},
"localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfStockByClassTable": {
"auth_ref": [
"r46",
"r102",
"r208",
"r209",
"r210",
"r212",
"r213",
"r214",
"r215",
"r216",
"r217",
"r218"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
"label": "Schedule of Stock by Class [Table]",
"terseLabel": "Schedule of Stock by Class [Table]"
}
}
},
"localname": "ScheduleOfStockByClassTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
"auth_ref": [
"r211"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
"label": "Schedule of Stockholders Equity [Table Text Block]",
"terseLabel": "Schedule of Stockholders Equity"
}
}
},
"localname": "ScheduleOfStockholdersEquityTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Debt and Equity Securities, FV-NI [Line Items]",
"terseLabel": "Debt and Equity Securities, FV-NI [Line Items]"
}
}
},
"localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).",
"label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]",
"terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]"
}
}
},
"localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
"auth_ref": [
"r220",
"r221",
"r222",
"r223"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
"label": "Class of Treasury Stock [Table Text Block]",
"terseLabel": "Schedule of Share Repurchase Activities"
}
}
},
"localname": "ScheduleOfTreasuryStockByClassTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
"auth_ref": [
"r192"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
"label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
"terseLabel": "Schedule Of Estimated Future Amortization Expense Of Intangible Assets"
}
}
},
"localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SellingGeneralAndAdministrativeExpense": {
"auth_ref": [
"r78",
"r173"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
"label": "Selling, General and Administrative Expense",
"terseLabel": "Selling, general and administrative"
}
}
},
"localname": "SellingGeneralAndAdministrativeExpense",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ServiceMember": {
"auth_ref": [
"r236"
],
"lang": {
"en-US": {
"role": {
"documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
"label": "Service [Member]",
"terseLabel": "Service"
}
}
},
"localname": "ServiceMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_ShareBasedCompensation": {
"auth_ref": [
"r93"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
"order": 6.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of noncash expense for share-based payment arrangement.",
"label": "Share-based Payment Arrangement, Noncash Expense",
"terseLabel": "Share-based compensation expense"
}
}
},
"localname": "ShareBasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
"auth_ref": [
"r254"
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
"negatedLabel": "Forfeited (in shares)",
"terseLabel": "Forfeited (in shares)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
"auth_ref": [
"r259"
],
"lang": {
"en-US": {
"role": {
"documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
"terseLabel": "Forfeited (usd per share)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
"auth_ref": [
"r257"
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
"terseLabel": "Granted (in shares)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
"auth_ref": [
"r257"
],
"lang": {
"en-US": {
"role": {
"documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
"terseLabel": "Granted (usd per share)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
"auth_ref": [
"r256"
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
"periodEndLabel": "Unvested ending balance (in shares)",
"periodStartLabel": "Unvested beginning balance (in shares)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
"terseLabel": "Shares"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
"auth_ref": [
"r256"
],
"lang": {
"en-US": {
"role": {
"documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
"periodEndLabel": "Unvested ending balance (usd per share)",
"periodStartLabel": "Unvested beginning balance (usd per share)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
"terseLabel": "Weighted\u00a0Average Grant Date Fair Value"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
"auth_ref": [
"r258"
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
"negatedTerseLabel": "Vested (in shares)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
"auth_ref": [
"r258"
],
"lang": {
"en-US": {
"role": {
"documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
"terseLabel": "Vested (usd per share)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
"auth_ref": [
"r265"
],
"lang": {
"en-US": {
"role": {
"documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
"terseLabel": "Risk-free interest rate"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
"auth_ref": [
"r264"
],
"lang": {
"en-US": {
"role": {
"documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
"terseLabel": "Expected volatility (percent)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
"terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails",
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
"auth_ref": [
"r268"
],
"lang": {
"en-US": {
"role": {
"documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
"terseLabel": "Common stock reserved for issuance"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
"auth_ref": [
"r251"
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
"terseLabel": "Options exercisable, number of shares"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
"auth_ref": [
"r251"
],
"lang": {
"en-US": {
"role": {
"documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
"terseLabel": "Options exercisable, weighted-average exercise price (usd per share)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
"auth_ref": [
"r255"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
"negatedLabel": "Options forfeited/expired, Number Outstanding"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
"auth_ref": [
"r252"
],
"lang": {
"en-US": {
"role": {
"documentation": "Net number of share options (or share units) granted during the period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
"terseLabel": "Options granted, Number Outstanding"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
"auth_ref": [
"r261"
],
"lang": {
"en-US": {
"role": {
"documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
"terseLabel": "Weighted average fair value at grant date (usd per share)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock": {
"auth_ref": [
"r261"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]",
"terseLabel": "Schedule of Estimated Fair Value of the Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
"auth_ref": [
"r250",
"r268"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of options outstanding, including both vested and non-vested options.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
"periodEndLabel": "Ending balance, Number Outstanding",
"periodStartLabel": "Beginning balance, Number Outstanding"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
"terseLabel": "Number Outstanding"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
"auth_ref": [
"r249"
],
"lang": {
"en-US": {
"role": {
"documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
"periodEndLabel": "Ending balance, Weighted Average Exercise Price Per Share",
"periodStartLabel": "Beginning balance, Weighted Average Exercise Price Per Share"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
"auth_ref": [
"r243",
"r247"
],
"lang": {
"en-US": {
"role": {
"documentation": "Award under share-based payment arrangement.",
"label": "Award Type [Domain]",
"terseLabel": "Award Type [Domain]"
}
}
},
"localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails",
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
"label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
"terseLabel": "Options exercised, Weighted Average Exercise Price Per Share"
}
}
},
"localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
"label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
"terseLabel": "Options forfeited/expired, Weighted Average Exercise Price Per Share"
}
}
},
"localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
"label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
"terseLabel": "Options granted, Weighted Average Exercise Price Per Share"
}
}
},
"localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareRepurchaseProgramAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by share repurchase program.",
"label": "Share Repurchase Program [Axis]",
"terseLabel": "Share Repurchase Program [Axis]"
}
}
},
"localname": "ShareRepurchaseProgramAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ShareRepurchaseProgramDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the share repurchase program.",
"label": "Share Repurchase Program [Domain]",
"terseLabel": "Share Repurchase Program [Domain]"
}
}
},
"localname": "ShareRepurchaseProgramDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
"auth_ref": [
"r263",
"r269"
],
"lang": {
"en-US": {
"role": {
"documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
"terseLabel": "Expected term (in years)"
}
}
},
"localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
],
"xbrltype": "durationItemType"
},
"us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
"label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
"negatedTerseLabel": "Shares withheld related to net share settlement of equity awards",
"terseLabel": "Shares withheld related to net share settlement of equity awards"
}
}
},
"localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_SignificantAccountingPoliciesTextBlock": {
"auth_ref": [
"r107"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
"label": "Significant Accounting Policies [Text Block]",
"terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
}
}
},
"localname": "SignificantAccountingPoliciesTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_StatementEquityComponentsAxis": {
"auth_ref": [
"r48",
"r211"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by component of equity.",
"label": "Equity Components [Axis]",
"terseLabel": "Equity Components [Axis]"
}
}
},
"localname": "StatementEquityComponentsAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Statement [Line Items]",
"terseLabel": "Statement [Line Items]"
}
}
},
"localname": "StatementLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfCashFlowsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statement of Cash Flows [Abstract]",
"terseLabel": "Statement of Cash Flows [Abstract]"
}
}
},
"localname": "StatementOfCashFlowsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfFinancialPositionAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statement of Financial Position [Abstract]",
"terseLabel": "Statement of Financial Position [Abstract]"
}
}
},
"localname": "StatementOfFinancialPositionAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementTable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
"label": "Statement [Table]",
"terseLabel": "Statement [Table]"
}
}
},
"localname": "StatementTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
"auth_ref": [
"r18",
"r19",
"r211",
"r218"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
"label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
"terseLabel": "Employee Stock Purchase Plan, number of shares purchased by employees"
}
}
},
"localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
"auth_ref": [
"r18",
"r19",
"r211",
"r218"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
"label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
"terseLabel": "Issuance of common stock through employee stock plans (in shares)"
}
}
},
"localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
"auth_ref": [
"r18",
"r19",
"r211",
"r218",
"r253"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of share options (or share units) exercised during the current period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
"negatedLabel": "Options exercised, Number Outstanding"
}
}
},
"localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
"auth_ref": [
"r18",
"r19",
"r211",
"r218"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
"label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
"terseLabel": "Employee Stock Purchase Plan, value of shares purchased by employees"
}
}
},
"localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
"auth_ref": [
"r18",
"r19",
"r218",
"r245",
"r261"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
"label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
"terseLabel": "Issuance of common stock through employee stock plans"
}
}
},
"localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockOptionMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
"label": "Equity Option [Member]",
"terseLabel": "Stock Options"
}
}
},
"localname": "StockOptionMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of stock repurchase plan authorized.",
"label": "Stock Repurchase Program, Authorized Amount",
"terseLabel": "Amount of share repurchases authorized"
}
}
},
"localname": "StockRepurchaseProgramAuthorizedAmount1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount remaining of a stock repurchase plan authorized.",
"label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
"terseLabel": "Remaining amount of share repurchases authorized"
}
}
},
"localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
"auth_ref": [
"r18",
"r19",
"r211",
"r218"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares that have been repurchased and retired during the period.",
"label": "Stock Repurchased and Retired During Period, Shares",
"negatedTerseLabel": "Repurchase and retirement of common stock (in shares)",
"terseLabel": "Shares repurchased (in shares)"
}
}
},
"localname": "StockRepurchasedAndRetiredDuringPeriodShares",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
"auth_ref": [
"r18",
"r19",
"r211",
"r218"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
"label": "Stock Repurchased and Retired During Period, Value",
"negatedTerseLabel": "Repurchase and retirement of common stock",
"terseLabel": "Value of shares repurchased"
}
}
},
"localname": "StockRepurchasedAndRetiredDuringPeriodValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockRepurchasedDuringPeriodShares": {
"auth_ref": [
"r18",
"r19",
"r211",
"r218"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
"label": "Stock Repurchased During Period, Shares",
"terseLabel": "Shares repurchased"
}
}
},
"localname": "StockRepurchasedDuringPeriodShares",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockholdersEquity": {
"auth_ref": [
"r19",
"r23",
"r24",
"r129"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
"label": "Stockholders' Equity Attributable to Parent",
"totalLabel": "Total Intuitive Surgical, Inc. stockholders\u2019 equity"
}
}
},
"localname": "StockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Stockholders' Equity Attributable to Parent [Abstract]",
"terseLabel": "Stockholders\u2019 equity:"
}
}
},
"localname": "StockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
"auth_ref": [
"r305",
"r306",
"r315"
],
"calculation": {
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
"label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
"periodEndLabel": "Ending balance",
"periodStartLabel": "Beginning balance",
"totalLabel": "Total stockholders\u2019 equity"
}
}
},
"localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
"auth_ref": [
"r224"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
"label": "Stockholders' Equity Note Disclosure [Text Block]",
"terseLabel": "STOCKHOLDERS' EQUITY"
}
}
},
"localname": "StockholdersEquityNoteDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": {
"auth_ref": [
"r275",
"r276"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.",
"label": "Tax Adjustments, Settlements, and Unusual Provisions",
"terseLabel": "Increase in income tax expense"
}
}
},
"localname": "TaxAdjustmentsSettlementsAndUnusualProvisions",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_TaxesPayableCurrent": {
"auth_ref": [
"r39"
],
"calculation": {
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails": {
"order": 1.0,
"parentTag": "us-gaap_OtherLiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
"label": "Taxes Payable, Current",
"terseLabel": "Taxes payable"
}
}
},
"localname": "TaxesPayableCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_TechnologyBasedIntangibleAssetsMember": {
"auth_ref": [
"r296"
],
"lang": {
"en-US": {
"role": {
"documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
"label": "Technology-Based Intangible Assets [Member]",
"terseLabel": "Technology-Based Intangible Assets [Member]"
}
}
},
"localname": "TechnologyBasedIntangibleAssetsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
"label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
"terseLabel": "Summary of Equity Investment Activity"
}
}
},
"localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
"auth_ref": [
"r373"
],
"lang": {
"en-US": {
"role": {
"documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
"label": "Financial Instruments [Domain]",
"terseLabel": "Financial Instruments [Domain]"
}
}
},
"localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
"auth_ref": [
"r220"
],
"lang": {
"en-US": {
"role": {
"documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
"label": "Treasury Stock Acquired, Average Cost Per Share",
"terseLabel": "Average price per share (in dollars per share)"
}
}
},
"localname": "TreasuryStockAcquiredAverageCostPerShare",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
"auth_ref": [
"r238",
"r379"
],
"lang": {
"en-US": {
"role": {
"documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
"label": "US Government Agencies Debt Securities [Member]",
"terseLabel": "U.S. government agencies"
}
}
},
"localname": "USGovernmentAgenciesDebtSecuritiesMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_USTreasurySecuritiesMember": {
"auth_ref": [
"r238",
"r241",
"r379"
],
"lang": {
"en-US": {
"role": {
"documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
"label": "US Treasury Securities [Member]",
"terseLabel": "U.S. treasuries"
}
}
},
"localname": "USTreasurySecuritiesMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities": {
"auth_ref": [
"r282"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase in unrecognized tax benefits resulting from settlements with taxing authorities.",
"label": "Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities",
"terseLabel": "Increase in unrecognized tax benefits"
}
}
},
"localname": "UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
"auth_ref": [
"r114"
],
"calculation": {
"http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails": {
"order": 2.0,
"parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
"weight": 1.0
}
},
"lang": {
"en-US": {
"role": {
"documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
"label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
"terseLabel": "Add: dilutive effect of potential common shares"
}
}
},
"localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
"auth_ref": [
"r110",
"r114"
],
"calculation": {
"http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"lang": {
"en-US": {
"role": {
"documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
"label": "Weighted Average Number of Shares Outstanding, Diluted",
"terseLabel": "Diluted (in shares)",
"totalLabel": "Weighted average shares outstanding used in diluted calculation"
}
}
},
"localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
"http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
"terseLabel": "Shares used in computing net income per share attributable to Intuitive Surgical, Inc.:",
"verboseLabel": "Denominator:"
}
}
},
"localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
"http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
"auth_ref": [
"r109",
"r114"
],
"calculation": {
"http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails": {
"order": 1.0,
"parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
"weight": 1.0
}
},
"lang": {
"en-US": {
"role": {
"documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
"label": "Weighted Average Number of Shares Outstanding, Basic",
"terseLabel": "Basic (in shares)",
"verboseLabel": "Weighted average shares outstanding used in basic calculation"
}
}
},
"localname": "WeightedAverageNumberOfSharesOutstandingBasic",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
"http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
],
"xbrltype": "sharesItemType"
}
},
"unitCount": 4
}
},
"std_ref": {
"r0": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
},
"r1": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
},
"r10": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765"
},
"r100": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(h))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
},
"r101": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(m)(1)(iii))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
},
"r102": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(d),(e))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
},
"r103": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(h)(1)(i))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
},
"r104": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(h)(2))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
},
"r105": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(n)(2))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
},
"r106": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.12-04(a))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
},
"r107": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "235",
"URI": "http://asc.fasb.org/topic&trid=2122369"
},
"r108": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
},
"r109": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256"
},
"r11": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765"
},
"r110": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256"
},
"r111": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256"
},
"r112": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256"
},
"r113": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
},
"r114": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
},
"r115": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
},
"r116": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
},
"r117": {
"Name": "Accounting Standards Codification",
"Paragraph": "52",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258"
},
"r118": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "260",
"URI": "http://asc.fasb.org/topic&trid=2144383"
},
"r119": {
"Name": "Accounting Standards Codification",
"Paragraph": "6A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "270",
"URI": "http://asc.fasb.org/extlink&oid=118952077&loc=SL77927221-108306"
},
"r12": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e7018-107765"
},
"r120": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r121": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "275",
"URI": "http://asc.fasb.org/topic&trid=2134479"
},
"r122": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
},
"r123": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
},
"r124": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
},
"r125": {
"Name": "Accounting Standards Codification",
"Paragraph": "40",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599"
},
"r126": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522"
},
"r127": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522"
},
"r128": {
"Name": "Accounting Standards Codification",
"Paragraph": "29",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=118936363&loc=SL6953659-111524"
},
"r129": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 4.E)",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
},
"r13": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
},
"r130": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26610-111562"
},
"r131": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26853-111562"
},
"r132": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
},
"r133": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(aa)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
},
"r134": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(aaa)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
},
"r135": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
},
"r136": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
},
"r137": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
},
"r138": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
},
"r139": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
},
"r14": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(1))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r140": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
},
"r141": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
},
"r142": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27290-111563"
},
"r143": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27337-111563"
},
"r144": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27340-111563"
},
"r145": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)-(d)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27357-111563"
},
"r146": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27357-111563"
},
"r147": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "321",
"URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117539-209714"
},
"r148": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "321",
"URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117546-209714"
},
"r149": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446"
},
"r15": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(13))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r150": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919244-210447"
},
"r151": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
},
"r152": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
},
"r153": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(f)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
},
"r154": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
},
"r155": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919253-210447"
},
"r156": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919258-210447"
},
"r157": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919230-210447"
},
"r158": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919232-210447"
},
"r159": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Subparagraph": "(e)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118955255&loc=SL82921835-210448"
},
"r16": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(14))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r160": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Subparagraph": "(e)(1)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118955255&loc=SL82921835-210448"
},
"r161": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Subparagraph": "(e)(2)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118955255&loc=SL82921835-210448"
},
"r162": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118955255&loc=SL82921842-210448"
},
"r163": {
"Name": "Accounting Standards Codification",
"Paragraph": "79",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118955255&loc=SL82922352-210448"
},
"r164": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118942338&loc=SL82898722-210454"
},
"r165": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118942338&loc=SL82922868-210454"
},
"r166": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922888-210455"
},
"r167": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922895-210455"
},
"r168": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922897-210455"
},
"r169": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922900-210455"
},
"r17": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(24))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r170": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(i)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922900-210455"
},
"r171": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922900-210455"
},
"r172": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "30",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118942371&loc=SL82922954-210456"
},
"r173": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "30",
"SubTopic": "10",
"Topic": "330",
"URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311"
},
"r174": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "35",
"SubTopic": "10",
"Topic": "330",
"URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312"
},
"r175": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 5.BB)",
"Topic": "330",
"URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
},
"r176": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "05",
"SubTopic": "10",
"Topic": "340",
"URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5865-108316"
},
"r177": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "05",
"SubTopic": "10",
"Topic": "340",
"URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
},
"r178": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Subparagraph": "(a)",
"Topic": "340",
"URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054"
},
"r179": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Subparagraph": "(b)",
"Topic": "340",
"URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054"
},
"r18": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(28))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r180": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
},
"r181": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975"
},
"r182": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
},
"r183": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(f)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
},
"r184": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(g)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
},
"r185": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
},
"r186": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267"
},
"r187": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
},
"r188": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
},
"r189": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(1)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
},
"r19": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(29))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r190": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(3)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
},
"r191": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(d)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
},
"r192": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r193": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(1)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r194": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(2)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r195": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(3)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r196": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(d)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r197": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "350",
"URI": "http://asc.fasb.org/topic&trid=2144416"
},
"r198": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
},
"r199": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
},
"r2": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
},
"r20": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(3))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r200": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
},
"r201": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
},
"r202": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "440",
"URI": "http://asc.fasb.org/topic&trid=2144648"
},
"r203": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349"
},
"r204": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e15243-108350"
},
"r205": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "450",
"URI": "http://asc.fasb.org/topic&trid=2127136"
},
"r206": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(4)",
"Topic": "460",
"URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12069-110248"
},
"r207": {
"Name": "Accounting Standards Codification",
"Paragraph": "12A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
},
"r208": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(CFRR 211.02)",
"Topic": "480",
"URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
},
"r209": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
},
"r21": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(1))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r210": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
},
"r211": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
},
"r212": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
},
"r213": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
},
"r214": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
},
"r215": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
},
"r216": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
},
"r217": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
},
"r218": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.3-04)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
},
"r219": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "25",
"SubTopic": "30",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
},
"r22": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(3))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r220": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
},
"r221": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
},
"r222": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
},
"r223": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
},
"r224": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "505",
"URI": "http://asc.fasb.org/topic&trid=2208762"
},
"r225": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044"
},
"r226": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044"
},
"r227": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130533-203044"
},
"r228": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045"
},
"r229": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045"
},
"r23": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r230": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(1)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045"
},
"r231": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(2)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045"
},
"r232": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045"
},
"r233": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045"
},
"r234": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
},
"r235": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
},
"r236": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
},
"r237": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "606",
"URI": "http://asc.fasb.org/topic&trid=49130388"
},
"r238": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(ii)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r239": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(iv)(01)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r24": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(31))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r240": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(i)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r241": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
},
"r242": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "35",
"SubTopic": "10",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899"
},
"r243": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
},
"r244": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
},
"r245": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
},
"r246": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
},
"r247": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a),(g)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r248": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r249": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)(i)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r25": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(32))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r250": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)(i)-(ii)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r251": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)(iii)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r252": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)(iv)(1)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r253": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)(iv)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r254": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)(iv)(3)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r255": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)(iv)(4)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r256": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(2)(i)-(ii)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r257": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(2)(iii)(1)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r258": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(2)(iii)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r259": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(2)(iii)(3)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r26": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(5))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r260": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r261": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)(1)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r262": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r263": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(2)(i)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r264": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(2)(ii)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r265": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(2)(iv)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r266": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)(1)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r267": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)(1)(i)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r268": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
},
"r269": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 14.D.2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
},
"r27": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(6)(a)(1))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r270": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 14.F)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
},
"r271": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907"
},
"r272": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907"
},
"r273": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "718",
"URI": "http://asc.fasb.org/topic&trid=2228938"
},
"r274": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "730",
"URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
},
"r275": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "25",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28511-109314"
},
"r276": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "25",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28446-109314"
},
"r277": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32123-109318"
},
"r278": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
},
"r279": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
},
"r28": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(6)(a)(3))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r280": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
},
"r281": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
},
"r282": {
"Name": "Accounting Standards Codification",
"Paragraph": "15A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(3)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
},
"r283": {
"Name": "Accounting Standards Codification",
"Paragraph": "15A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
},
"r284": {
"Name": "Accounting Standards Codification",
"Paragraph": "19",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
},
"r285": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
},
"r286": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
},
"r287": {
"Name": "Accounting Standards Codification",
"Paragraph": "217",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=117331294&loc=d3e36027-109320"
},
"r288": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 6.I.7)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
},
"r289": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
},
"r29": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(6)(a)(4))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r290": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "740",
"URI": "http://asc.fasb.org/topic&trid=2144680"
},
"r291": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "25",
"SubTopic": "10",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
},
"r292": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
},
"r293": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
},
"r294": {
"Name": "Accounting Standards Codification",
"Paragraph": "37",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=116868840&loc=d3e2207-128464"
},
"r295": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472"
},
"r296": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5227-128473"
},
"r297": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Subparagraph": "(e)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473"
},
"r298": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473"
},
"r299": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "25",
"SubTopic": "30",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
},
"r3": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
},
"r30": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(6)(a))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r300": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "30",
"SubTopic": "30",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
},
"r301": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "30",
"SubTopic": "30",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
},
"r302": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "35",
"SubTopic": "30",
"Subparagraph": "b",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
},
"r303": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(b)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
},
"r304": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(b)(1)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
},
"r305": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
},
"r306": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
},
"r307": {
"Name": "Accounting Standards Codification",
"Paragraph": "19",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
},
"r308": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
},
"r309": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
},
"r31": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(6)(b))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r310": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(1)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r311": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(2)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r312": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r313": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(3)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r314": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c),(3)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r315": {
"Name": "Accounting Standards Codification",
"Paragraph": "4I",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686"
},
"r316": {
"Name": "Accounting Standards Codification",
"Paragraph": "4J",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686"
},
"r317": {
"Name": "Accounting Standards Codification",
"Paragraph": "4K",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686"
},
"r318": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.3A-02)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828"
},
"r319": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.3A-03)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828"
},
"r32": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(6)(c))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r320": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.3A-04)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355119-122828"
},
"r321": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959"
},
"r322": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
},
"r323": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
},
"r324": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959"
},
"r325": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
},
"r326": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "c",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
},
"r327": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
},
"r328": {
"Name": "Accounting Standards Codification",
"Paragraph": "4A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
},
"r329": {
"Name": "Accounting Standards Codification",
"Paragraph": "4A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
},
"r33": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(7))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r330": {
"Name": "Accounting Standards Codification",
"Paragraph": "4A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(1)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
},
"r331": {
"Name": "Accounting Standards Codification",
"Paragraph": "4B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
},
"r332": {
"Name": "Accounting Standards Codification",
"Paragraph": "4B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
},
"r333": {
"Name": "Accounting Standards Codification",
"Paragraph": "4B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
},
"r334": {
"Name": "Accounting Standards Codification",
"Paragraph": "4C",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
},
"r335": {
"Name": "Accounting Standards Codification",
"Paragraph": "4C",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
},
"r336": {
"Name": "Accounting Standards Codification",
"Paragraph": "4CC",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998890-113959"
},
"r337": {
"Name": "Accounting Standards Codification",
"Paragraph": "4D",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
},
"r338": {
"Name": "Accounting Standards Codification",
"Paragraph": "4E",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959"
},
"r339": {
"Name": "Accounting Standards Codification",
"Paragraph": "4F",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624186-113959"
},
"r34": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(8))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r340": {
"Name": "Accounting Standards Codification",
"Paragraph": "4K",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(4)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5708775-113959"
},
"r341": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959"
},
"r342": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959"
},
"r343": {
"Name": "Accounting Standards Codification",
"Paragraph": "182",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961"
},
"r344": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109978405&loc=d3e80720-113993"
},
"r345": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r346": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r347": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(bb)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r348": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
},
"r349": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
},
"r35": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.1)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r350": {
"Name": "Accounting Standards Codification",
"Paragraph": "5A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=116690757&loc=SL116692626-108610"
},
"r351": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894"
},
"r352": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30700-110894"
},
"r353": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
},
"r354": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "230",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
},
"r355": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
},
"r356": {
"Name": "Accounting Standards Codification",
"Paragraph": "18",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32157-110900"
},
"r357": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(b,c)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r358": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(d)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r359": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r36": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.12)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r360": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
},
"r361": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "840",
"URI": "http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737"
},
"r362": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"SubTopic": "30",
"Topic": "840",
"URI": "http://asc.fasb.org/subtopic&trid=2209026"
},
"r363": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "842",
"URI": "http://asc.fasb.org/extlink&oid=77888421&loc=SL77919311-209978"
},
"r364": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "842",
"URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919391-209981"
},
"r365": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(3)",
"Topic": "842",
"URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919359-209981"
},
"r366": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "842",
"URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919359-209981"
},
"r367": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "842",
"URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919372-209981"
},
"r368": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "842",
"URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919379-209981"
},
"r369": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"SubTopic": "30",
"Topic": "842",
"URI": "http://asc.fasb.org/subtopic&trid=77888252"
},
"r37": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.17)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r370": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(bb)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
},
"r371": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(bb)(1)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
},
"r372": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(bb)(2)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
},
"r373": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
},
"r374": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "340",
"Topic": "928",
"URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
},
"r375": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(11))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
},
"r376": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(15)(1))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
},
"r377": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(22))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
},
"r378": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(23))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
},
"r379": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(6)(a)(1))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
},
"r38": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19(a))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r380": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03.17)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
},
"r381": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(22))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
},
"r382": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(23))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
},
"r383": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "320",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62557-112803"
},
"r384": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "320",
"Subparagraph": "(a)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
},
"r385": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "320",
"Subparagraph": "(b)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
},
"r386": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "320",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
},
"r387": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(12))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r388": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r389": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r39": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19,20)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r390": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(24))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r391": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(25))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r392": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(8))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r393": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03.(a),19)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r394": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(18))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
},
"r395": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(19))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
},
"r396": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04.3(a))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
},
"r397": {
"Name": "Accounting Standards Codification",
"Paragraph": "4H",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
},
"r398": {
"Name": "Accounting Standards Codification",
"Paragraph": "13H",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "40",
"Subparagraph": "(a)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
},
"r399": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "80",
"Subparagraph": "(e)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=117420044&loc=d3e19393-158473"
},
"r4": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(g)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
},
"r40": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19-26)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r400": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "985",
"URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
},
"r401": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b"
},
"r402": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "d1-1"
},
"r403": {
"Name": "Form 10-Q",
"Number": "240",
"Publisher": "SEC",
"Section": "13",
"Subsection": "a-13"
},
"r404": {
"Name": "Forms 10-K, 10-Q, 20-F",
"Number": "240",
"Publisher": "SEC",
"Section": "13",
"Subsection": "a-1-"
},
"r405": {
"Name": "Regulation 12B",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b-2"
},
"r406": {
"Name": "Regulation S-T",
"Number": "232",
"Publisher": "SEC",
"Section": "405"
},
"r41": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.2)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r42": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.20)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r43": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.21)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r44": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.24)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r45": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.25)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r46": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.28,29)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r47": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.29)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r48": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.29-31)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r49": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.31)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r5": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(g)(4)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
},
"r50": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.6(a))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r51": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.9)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r52": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
},
"r53": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
},
"r54": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a-c)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
},
"r55": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
},
"r56": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
},
"r57": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
},
"r58": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(i-k)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
},
"r59": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
},
"r6": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
},
"r60": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580"
},
"r61": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580"
},
"r62": {
"Name": "Accounting Standards Codification",
"Paragraph": "14A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
},
"r63": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e689-108580"
},
"r64": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e709-108580"
},
"r65": {
"Name": "Accounting Standards Codification",
"Paragraph": "17A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724391-108580"
},
"r66": {
"Name": "Accounting Standards Codification",
"Paragraph": "17B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
},
"r67": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
},
"r68": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
},
"r69": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
},
"r7": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6787-107765"
},
"r70": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
},
"r71": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
},
"r72": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580"
},
"r73": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581"
},
"r74": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(20))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r75": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(21))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r76": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.1,2)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r77": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.2(a),(d))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r78": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.4)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r79": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.7)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r8": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
},
"r80": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3151-108585"
},
"r81": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
},
"r82": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a),(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
},
"r83": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
},
"r84": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
},
"r85": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
},
"r86": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
},
"r87": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
},
"r88": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
},
"r89": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
},
"r9": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6904-107765"
},
"r90": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585"
},
"r91": {
"Name": "Accounting Standards Codification",
"Paragraph": "24",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
},
"r92": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
},
"r93": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
},
"r94": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
},
"r95": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
},
"r96": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
},
"r97": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586"
},
"r98": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
},
"r99": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(a))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
}
},
"version": "2.1"
} |
